RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Sepsis
Accession: DOID:9004484
browse the term
Definition: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
Synonyms: exact_synonym: Blood Poisoning; Pyaemia; Pyaemias; Pyemia; Pyemias; Pyohemia; Pyohemias; Septicemia; Septicemias; blood poisonings
narrow_synonym: septic shock; severe sepsis
related_synonym: SEPSIS, SUSCEPTIBILITY TO
primary_id: MESH:D018805
xref: EFO:0001420
G
A2m
alpha-2-macroglobulin
ISO
mRNA:increased expression:liver
RGD
PMID:9843780 PMID:15167684
RGD:1598509 , RGD:10046033
NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
severity
ISO
DNA:polymorphism:cds:allele A (human)
RGD
PMID:4375858
RGD:39938844
NCBI chr 2:26,732,508...26,754,973
Ensembl chr 2:26,732,515...26,754,991
G
Ace
angiotensin I converting enzyme
susceptibility
ISO
DNA:insertion/deletion:intron:
RGD
PMID:19143971
RGD:40400706
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO IMP IEP
mRNA, protein:decreasedexpression:serum, omental fat pad:
RGD
PMID:16488436 PMID:19481767 PMID:21962804
RGD:1599144 , RGD:5686835 , RGD:5686408
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adm
adrenomedullin
treatment
ISO
protein:increased expression:plasma: CTD Direct Evidence: marker/mechanism associated with Jaundice,Obstructive;
CTD RGD
PMID:14766677 PMID:20132852 PMID:19009024 PMID:20132852
RGD:7364952 , RGD:7364986 , RGD:7364952
NCBI chr 7:110,226,864...110,229,027
Ensembl chr 7:110,226,868...110,229,027
G
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27757725
NCBI chr10:75,152,711...75,170,626
Ensembl chr10:75,152,711...75,170,618
G
Adora2b
adenosine A2b receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27757725
NCBI chr11:62,139,810...62,157,278
Ensembl chr11:62,139,810...62,157,279
G
Adra2a
adrenergic receptor, alpha 2a
disease_progression
ISO
RGD
PMID:19894027
RGD:6480483
NCBI chr19:54,033,690...54,037,413
Ensembl chr19:54,032,582...54,037,413
G
Adrb2
adrenergic receptor, beta 2
ISO
mRNA,protein:decreased expression:liver:
RGD
PMID:16603198 PMID:10409266
RGD:1598745 , RGD:8548498
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
G
Adrb3
adrenergic receptor, beta 3
ISO
mRNA, protein:increased expression:heart left ventricle (human)
RGD
PMID:17999941
RGD:2292119
NCBI chr 8:27,715,804...27,720,833
Ensembl chr 8:27,715,804...27,740,644
G
Ager
advanced glycosylation end product-specific receptor
treatment
ISO
RGD
PMID:19623040
RGD:10402067
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Alas1
aminolevulinic acid synthase 1
ISO
mRNA:increased expression:duodenum, jejunum, ileum (rat)
RGD
PMID:12627002
RGD:4144178
NCBI chr 9:106,110,654...106,125,153
Ensembl chr 9:106,110,654...106,125,853
G
Alb
albumin
disease_progression
ISO
protein:decreased expression:serum:
RGD
PMID:22801198
RGD:11036079
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
treatment
ISO
associated with heat shock treatment;protein:altered expression, altered phosphorylation:liver, mitochondria (rat)
RGD
PMID:17607160
RGD:15036802
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Angpt1
angiopoietin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16005988
NCBI chr15:42,288,063...42,540,373
Ensembl chr15:42,288,119...42,540,373
G
Apoa1
apolipoprotein A-I
treatment
ISO
RGD
PMID:19561306
RGD:7241869
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Arg2
arginase type II
ISO
protein:decreased expression:lung
RGD
PMID:9635249
RGD:1626297
NCBI chr12:79,177,562...79,203,075
Ensembl chr12:79,177,551...79,203,075
G
Atm
ataxia telangiectasia mutated
treatment
IMP
RGD
PMID:24184056
RGD:126781746
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
G
Atp2a1
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
ISO
RGD
PMID:28446393
RGD:13782063
NCBI chr 7:126,045,032...126,062,245
Ensembl chr 7:126,045,030...126,062,280
G
Baat
bile acid-Coenzyme A: amino acid N-acyltransferase
ISO
RGD
PMID:7575455
RGD:69770
NCBI chr 4:49,489,416...49,507,915
Ensembl chr 4:49,489,422...49,506,557
G
Bad
BCL2-associated agonist of cell death
treatment
ISO
protein:increased localization:mitochondrion
RGD
PMID:24011917 PMID:22683079
RGD:10053647 , RGD:10053707
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
C3
complement component 3
ISO IEP
protein:increased expression:liver mRNA:increased expression:kidney
RGD
PMID:3339873 PMID:24154627
RGD:7411622 , RGD:11040886
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
C5ar1
complement component 5a receptor 1
disease_progression
ISO
RGD
PMID:12897064 PMID:18648551
RGD:5130176 , RGD:5130170
NCBI chr 7:15,980,668...15,993,465
Ensembl chr 7:15,980,668...15,993,465
G
C6
complement component 6
severity
ISO
RGD
PMID:15638131
RGD:1600672
NCBI chr15:4,756,550...4,833,527
Ensembl chr15:4,756,657...4,844,449
G
Cacna1s
calcium channel, voltage-dependent, L type, alpha 1S subunit
ISO
protein:decreased expression:diaphragmaticus muscle
RGD
PMID:28044347
RGD:329849111
NCBI chr 1:135,980,549...136,047,268
Ensembl chr 1:135,980,488...136,047,560
G
Camp
cathelicidin antimicrobial peptide
ISO
RGD
PMID:17142779
RGD:2316243
NCBI chr 9:109,676,445...109,678,524
Ensembl chr 9:109,676,447...109,678,685
G
Casp3
caspase 3
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16003065 PMID:32062619 PMID:29180187
RGD:13782295
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp6
caspase 6
ISO
protein:increased activity:thymus, T cell
RGD
PMID:11086028
RGD:2301332
NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752
G
Casp8
caspase 8
treatment
ISO
RGD
PMID:18570579 PMID:29180187
RGD:2311435 , RGD:13782295
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Casp9
caspase 9
treatment
ISO
RGD
PMID:29180187
RGD:13782295
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cast
calpastatin
ISO
RGD
PMID:15563579
RGD:5683871
NCBI chr13:74,840,485...74,956,993
Ensembl chr13:74,840,487...74,956,929
G
Cat
catalase
severity
ISO
RGD
PMID:15836852
RGD:9068893
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cbs
cystathionine beta-synthase
susceptibility
ISO
DNA:SNP:intron (rs6586282, rs34758144) (human)
RGD
PMID:26508567
RGD:40903018
NCBI chr17:31,831,602...31,856,170
Ensembl chr17:31,827,868...31,856,212
G
Ccl11
C-C motif chemokine ligand 11
ISO
RGD
PMID:21652218
RGD:7248417
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
G
Ccl2
C-C motif chemokine ligand 2
ISO
mRNA:increased expression:ileum
RGD
PMID:19111613
RGD:2307002
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl4
C-C motif chemokine ligand 4
severity
ISO
RGD
PMID:21208283
RGD:5683911
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased secretion:plasma (rat)
RGD
PMID:18290317
RGD:4890036
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Cd163
CD163 antigen
ISO
protein:increased expression:blood serum, CD-14 positive monocyte (human)
RGD
PMID:24637679
RGD:127285802
NCBI chr 6:124,281,596...124,307,488
Ensembl chr 6:124,281,615...124,307,486
G
Cd1d1
CD1d1 antigen
treatment
IMP
RGD
PMID:14572776
RGD:127345103
NCBI chr 3:86,903,141...86,919,665
Ensembl chr 3:86,903,141...86,906,748
G
Cd209a
CD209a antigen
IMP
RGD
PMID:23254286
RGD:39938991
NCBI chr 8:3,793,395...3,798,984
Ensembl chr 8:3,793,397...3,798,984
G
Cd274
CD274 antigen
disease_progression
ISO
protein:increased expression:monocyte protein:increased expression:B cell,CD4T cell
RGD
PMID:30595665 PMID:27156867 PMID:29702526 PMID:29661225
RGD:40818235 , RGD:41412183 , RGD:40822808 , RGD:40818424
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
G
Cd28
CD28 antigen
severity
ISO
Higher soluble CD28 in human patients that died
RGD
PMID:17989345
RGD:5131622
NCBI chr 1:60,785,547...60,812,521
Ensembl chr 1:60,755,959...60,812,518
G
Cd36
CD36 molecule
IMP
RGD
PMID:22327076
RGD:6893490
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
G
Cd40
CD40 antigen
ISO
protein:decreased nitrosylation:monocyte
RGD
PMID:20473113
RGD:5490974
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cd40lg
CD40 ligand
ISO
mRNA:increased expression:heart (rat)
RGD
PMID:20933523
RGD:11352671
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
ISO
RGD
PMID:10451498
RGD:10043817
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cebpb
CCAAT/enhancer binding protein beta
ISO
protein:increased expression:skeletal muscle
RGD
PMID:11792653
RGD:625506
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
G
Cebpd
CCAAT/enhancer binding protein delta
ISO
protein:increased expression:skeletal muscle
RGD
PMID:11792653
RGD:625506
NCBI chr16:15,705,150...15,707,409
Ensembl chr16:15,705,150...15,708,895
G
Cfb
complement factor B
treatment
IMP
RGD
PMID:24154627
RGD:11040886
NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494
G
Cfh
complement component factor h
treatment
ISO
protein:decreased expression:plasma: associated with Jaundice,Obstructive;
RGD
PMID:20132852 PMID:19009024 PMID:20132852
RGD:7364952 , RGD:7364986 , RGD:7364952
NCBI chr 1:140,013,593...140,111,149
Ensembl chr 1:140,012,446...140,111,502
G
Cpb2
carboxypeptidase B2
ISO
protein:increased activity:plasma:
RGD
PMID:15497025
RGD:2313648
NCBI chr14:75,479,727...75,520,995
Ensembl chr14:75,479,727...75,520,995
G
Crh
corticotropin releasing hormone
ISO
protein:increased expression:hypothalamus (rat)
RGD
PMID:21549066
RGD:5490558
NCBI chr 3:19,747,565...19,749,560
Ensembl chr 3:19,747,565...19,749,560
G
Crp
C-reactive protein, pentraxin-related
ISO
protein:increased expression:blood:
RGD
PMID:21797109 PMID:19060982
RGD:6482315 , RGD:9491784
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Cs
citrate synthase
ISO
protein:decreased expression:cerebral cortex
RGD
PMID:25299715
RGD:329337347
NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
G
Csf2
colony stimulating factor 2 (granulocyte-macrophage)
ISO
protein:increased expression:plasma:
RGD
PMID:10664226
RGD:10449523
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
G
Csf3
colony stimulating factor 3 (granulocyte)
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:17505274 PMID:8706460
RGD:11039434
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Cx3cr1
C-X3-C motif chemokine receptor 1
ISO
protein:increased expression:lung, macrophage
RGD
PMID:19733456
RGD:4144897
NCBI chr 9:119,877,749...119,897,362
Ensembl chr 9:119,877,749...119,898,945
G
Cxcl15
C-X-C motif chemokine ligand 15
exacerbates
ISO
protein:increased expression:blood plasma (human)
RGD
PMID:31818332
RGD:40924635
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cxcl2
C-X-C motif chemokine ligand 2
IMP
RGD
PMID:9284162
RGD:5135255
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cxcl5
C-X-C motif chemokine ligand 5
IEP
protein:increased expression:multiple tissues
RGD
PMID:9284162
RGD:5135255
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
G
Cxcr2
C-X-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17138957
NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,150...74,200,405
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:15665729
RGD:5147745
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
ISO
RGD
PMID:18360687 PMID:15665729
RGD:2303376 , RGD:5147745
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp2b10
cytochrome P450, family 2, subfamily b, polypeptide 10
ISO
RGD
PMID:15665729
RGD:5147745
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
RGD
PMID:15665729
RGD:5147745
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Cyp2j6
cytochrome P450, family 2, subfamily j, polypeptide 6
ISO
RGD
PMID:15190971
RGD:1625384
NCBI chr 4:96,404,375...96,449,835
Ensembl chr 4:96,404,375...96,441,898
G
Cyp2j9
cytochrome P450, family 2, subfamily j, polypeptide 9
ISO
RGD
PMID:15190971
RGD:1625384
NCBI chr 4:96,456,661...96,480,748
Ensembl chr 4:96,456,666...96,479,815
G
Defb2
defensin beta 2
treatment
ISO
RGD
PMID:17177330
RGD:9685178
NCBI chr 8:22,329,942...22,333,519
Ensembl chr 8:22,329,942...22,333,498
G
Edn1
endothelin 1
ISO
mRNA, protein:increased expression:multiple (rat)
RGD
PMID:10838194
RGD:8662298
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Eif2b5
eukaryotic translation initiation factor 2B, subunit 5 epsilon
ISO
protein:increased serine phosphorylation:gastrocnemius
RGD
PMID:12376332
RGD:11041880
NCBI chr16:20,317,544...20,328,073
Ensembl chr16:20,317,567...20,328,073
G
Eif2s1
eukaryotic translation initiation factor 2, subunit 1 alpha
ISO
RGD
PMID:8141277
RGD:10395355
NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784
G
Eif4e
eukaryotic translation initiation factor 4E
ISO
RGD
PMID:17709445
RGD:10401144
NCBI chr 3:138,231,952...138,265,457
Ensembl chr 3:138,231,940...138,265,457
G
Elane
elastase, neutrophil expressed
IMP
associated with Klebsiella Infections;
RGD
PMID:9585238
RGD:10450543
NCBI chr10:79,722,146...79,724,050
Ensembl chr10:79,722,081...79,724,049
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
ISO
protein:increased activity:lymphocyte:
RGD
PMID:22645477
RGD:9685487
NCBI chr19:40,600,810...40,730,046
Ensembl chr19:40,600,810...40,730,046
G
Ep300
E1A binding protein p300
ISO
mRNA, protein:increased expression:muscle part of extensor digitorum longus (rat)
RGD
PMID:20538901
RGD:7364733
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
G
Esr2
estrogen receptor 2 (beta)
ISO
RGD
PMID:16755255
RGD:5508850
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
F11
coagulation factor XI
ISO
RGD
PMID:12000738
RGD:1598921
NCBI chr 8:45,693,696...45,715,092
Ensembl chr 8:45,694,211...45,715,068
G
F2
coagulation factor II
treatment
ISO
RGD
PMID:19705256 PMID:12361199
RGD:7387324 , RGD:10449428
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
F3
coagulation factor III
treatment
ISO
RGD
PMID:9875912 PMID:26311287
RGD:11340217 , RGD:11341736
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
F5
coagulation factor V
severity treatment
ISO
RGD
PMID:16235188 PMID:12000738
RGD:4892622 , RGD:1598921
NCBI chr 1:163,979,396...164,048,539
Ensembl chr 1:163,979,407...164,047,846
G
F7
coagulation factor VII
treatment
ISO
protein:decreased activity:plasma (rat)
RGD
PMID:3660344 PMID:12000738
RGD:2312320 , RGD:1598921
NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
G
F9
coagulation factor IX
treatment
ISO
RGD
PMID:12000738
RGD:1598921
NCBI chr X:59,044,675...59,076,120
Ensembl chr X:59,044,824...59,076,119
G
Fas
Fas cell surface death receptor
ISO
mRNA:increased expression:liver
RGD
PMID:17899301
RGD:2290175
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fasl
Fas ligand
ISO
mRNA:increased expression:liver
RGD
PMID:17899301
RGD:2290175
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
G
Fga
fibrinogen alpha chain
ISO
protein:decreased expression:serum (rat)
RGD
PMID:24667622
RGD:9685020
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
G
Flt1
FMS-like tyrosine kinase 1
disease_progression
ISO
Pneumonia associated sepsis
RGD
PMID:21219633
RGD:4891938
NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821
G
Foxp3
forkhead box P3
severity
ISO
RGD
PMID:25403265
RGD:38455982
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
G
Fyn
Fyn proto-oncogene
ISO
protein:decreased phosphorylation, decreased activity:T cell (rat)
RGD
PMID:9551931
RGD:2324866
NCBI chr10:39,245,735...39,441,377
Ensembl chr10:39,244,851...39,441,377
G
Gas6
growth arrest specific 6
ISO
RGD
PMID:16374177
RGD:1579935
NCBI chr 8:13,515,374...13,544,535
Ensembl chr 8:13,515,374...13,544,490
G
Gata3
GATA binding protein 3
severity
ISO
RGD
PMID:25403265
RGD:38455982
NCBI chr 2:9,861,889...9,894,845
Ensembl chr 2:9,861,889...9,894,845
G
Gch1
GTP cyclohydrolase 1
treatment
ISO
associated with Staphylococcal Infections
RGD
PMID:12441764 PMID:29428597
RGD:401700401 , RGD:401717570
NCBI chr14:47,391,352...47,426,870
Ensembl chr14:47,391,352...47,426,870
G
Gfer
growth factor, augmenter of liver regeneration
ISO
protein:increased expression:serum:
RGD
PMID:23073658
RGD:9685733
NCBI chr17:24,912,164...24,915,065
Ensembl chr17:24,912,161...24,915,503
G
Ghr
growth hormone receptor
ISO
RGD
PMID:11126270
RGD:2307382
NCBI chr15:3,347,237...3,612,834
Ensembl chr15:3,347,242...3,612,974
G
Ghrl
ghrelin
ISO
mRNA,protein:decreased expression:aorta,heart, intestine, plasma:
RGD
PMID:15155262
RGD:12905047
NCBI chr 6:113,693,080...113,696,872
Ensembl chr 6:113,693,080...113,696,841
G
Ghsr
growth hormone secretagogue receptor
disease_progression
ISO
RGD
PMID:15155262
RGD:12905047
NCBI chr 3:27,425,500...27,433,384
Ensembl chr 3:27,425,500...27,432,159
G
Gja5
gap junction protein, alpha 5
ISO
mRNA, protein:increased expression:aorta endothelium
RGD
PMID:15942348
RGD:7207815
NCBI chr 3:96,939,718...96,960,950
Ensembl chr 3:96,812,009...96,984,732
G
Gp1ba
glycoprotein 1b, alpha polypeptide
exacerbates
IMP
associated with thrombocytopenia
RGD
PMID:24150174
RGD:42722621
NCBI chr11:70,529,928...70,534,812
Ensembl chr11:70,529,948...70,532,862
G
Gpt
glutamic pyruvic transaminase, soluble
treatment
ISO
RGD
PMID:26814114 PMID:25243423
RGD:14975161 , RGD:401717564
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Grin2a
glutamate receptor, ionotropic, NMDA2A (epsilon 1)
ISO
protein:increased expression:lung (rat)
RGD
PMID:19837828
RGD:2325949
NCBI chr16:9,385,765...9,813,744
Ensembl chr16:9,385,762...9,813,424
G
Grk2
G protein-coupled receptor kinase 2
ISO
protein: increased expression: neutrophils
RGD
PMID:16849637
RGD:5688378
NCBI chr19:4,336,029...4,356,356
Ensembl chr19:4,336,029...4,356,250
G
Grk5
G protein-coupled receptor kinase 5
ISO
protein: increased expression: neutrophils
RGD
PMID:16849637
RGD:5688378
NCBI chr19:60,877,995...61,084,406
Ensembl chr19:60,878,187...61,084,406
G
Gsk3b
glycogen synthase kinase 3 beta
ISO
protein:decreased phosphorylation,increased activity: :
RGD
PMID:20926980
RGD:10045370
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
G
Gsn
gelsolin
ISO
protein:decreased expression:blood serum (human)
RGD
PMID:9142022
RGD:329333022
NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904
G
Havcr1
hepatitis A virus cellular receptor 1
disease_progression
ISO
RGD
PMID:23131280
RGD:7245480
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
G
Hc
hemolytic complement
ISO
protein:increased activation:plasma
RGD
PMID:18648551 PMID:14688199
RGD:5130170 , RGD:1600599
NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450
G
Hdac4
histone deacetylase 4
ISO
RGD
PMID:23925573
RGD:9681446
NCBI chr 1:91,856,501...92,123,424
Ensembl chr 1:91,856,501...92,123,421
G
Hdac6
histone deacetylase 6
ISO
RGD
PMID:20538901
RGD:7364733
NCBI chr X:7,796,355...7,814,284
Ensembl chr X:7,796,359...7,814,128
G
Hmgb1
high mobility group box 1
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19265175 PMID:23146691 PMID:19623040 PMID:20936717
RGD:10402067 , RGD:10402173
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Hpgd
hydroxyprostaglandin dehydrogenase 15 (NAD)
IEP
protein: decreased expression
RGD
PMID:9603077
RGD:5688768
NCBI chr 8:56,747,587...56,774,081
Ensembl chr 8:56,747,620...56,774,078
G
Hspd1
heat shock protein 1 (chaperonin)
ISO
associated with burns;protein:decreased expression:skeletal muscle
RGD
PMID:16483253 PMID:23143056
RGD:1624233 , RGD:10402864
NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
G
Htra2
HtrA serine peptidase 2
treatment
ISO
RGD
PMID:23557966
RGD:10402934
NCBI chr 6:83,028,247...83,031,552
Ensembl chr 6:83,028,247...83,032,254
G
Icam1
intercellular adhesion molecule 1
ISO
mRNA:increased expression:brain (rat)
RGD
PMID:20451670
RGD:4145409
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ido1
indoleamine 2,3-dioxygenase 1
treatment
IMP
RGD
PMID:25114116
RGD:39938864
NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
G
Ifng
interferon gamma
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9806674 PMID:27598601 PMID:28711488
RGD:14975121 , RGD:14974250
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Il10
interleukin 10
treatment
ISO IDA IEP
protein:increased expression:serum CTD Direct Evidence: therapeutic
CTD RGD
PMID:11441115 PMID:19371254 PMID:27488951 PMID:28108420 PMID:24055021
RGD:2311053 , RGD:14975262 , RGD:14975261 , RGD:7364867
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il12b
interleukin 12b
ISO
protein:increased expression:peritoneal fluid, plasma
RGD
PMID:15776385
RGD:4888507
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
G
Il13
interleukin 13
IMP ISO
protein:decreased expression:ileum
RGD
PMID:10679115 PMID:21159497
RGD:4145654 , RGD:8549643
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il16
interleukin 16
IEP
associated with Shock, Hemorrhagic;protein:increased expression:lung
RGD
PMID:19641139
RGD:5024925
NCBI chr 7:83,292,027...83,395,479
Ensembl chr 7:83,292,033...83,394,934
G
Il17a
interleukin 17A
ISO
RGD
PMID:15776385
RGD:4888507
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il17d
interleukin 17D
severity treatment
IDA ISO IMP
protein:increased expression:blood serum (human)
RGD
PMID:31634237 PMID:31634237 PMID:31634237
RGD:40903064 , RGD:40903064 , RGD:40903064
NCBI chr14:57,762,197...57,780,623
Ensembl chr14:57,762,234...57,780,623
G
Il1b
interleukin 1 beta
treatment
ISO
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:32062619 PMID:17529909 PMID:21429520
RGD:1626657 , RGD:7175319
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rl1
interleukin 1 receptor-like 1
severity
IMP
RGD
PMID:30001716
RGD:39938964
NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575
G
Il1rn
interleukin 1 receptor antagonist
susceptibility disease_progression severity
IEP ISO
mRNA, protein:increased expression:lung associated with Premature Birth;DNA:polymorphism:: DNA:repeats: : mRNA:increased expression:pituitary gland (rat) protein:increased expression:serum (human)
RGD
PMID:20454520 PMID:22882323 PMID:11876758 PMID:10048466 PMID:8196140 PMID:17014550 More...
RGD:4142852 , RGD:12910846 , RGD:11528543 , RGD:7175061 , RGD:6909139 , RGD:6907358
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il22
interleukin 22
ISO
protein:increased expression:plasma
RGD
PMID:19664145
RGD:5147412
NCBI chr10:118,040,456...118,045,952
Ensembl chr10:118,040,847...118,045,952
G
Il27
interleukin 27
exacerbates severity disease_progression
ISO IEP IMP
protein:increased expression:blood (human) mRNA:increased expression:blood, leukocyte (human) associated with Herpesviridae Infections;protein:increased expression:blood serum, spleen (mouse) DNA:SNP:promoter:-964A>G (rs153109) (human)
RGD
PMID:22965735 PMID:18227999 PMID:20493722 PMID:26767500 PMID:30268141
RGD:126790502 , RGD:126790544 , RGD:126790537 , RGD:126790536 , RGD:126790509
NCBI chr 7:126,188,181...126,194,197
Ensembl chr 7:126,188,182...126,194,113
G
Il33
interleukin 33
severity
IMP IEP ISO
protein:increased expression:plasma, peritoneal fluid: protein:increased expression:plasma: protein:increased expression:plasma,lung
RGD
PMID:29672927 PMID:29935165 PMID:29935165 PMID:25665614 PMID:29672927
RGD:39939028 , RGD:40400895 , RGD:40400895 , RGD:40400739 , RGD:39939028
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
Il4
interleukin 4
ISO
protein:increased expression:plasma
RGD
PMID:25403265
RGD:38455982
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Il6
interleukin 6
treatment
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent; mRNA, protein:increased expression:liver, extracellular space (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:32062619 PMID:19079684 PMID:27598601 PMID:25317848
RGD:2307280 , RGD:14975121 , RGD:11062009
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Irak4
interleukin-1 receptor-associated kinase 4
ISO
RGD
PMID:23073793
RGD:7495805
NCBI chr15:94,441,495...94,466,198
Ensembl chr15:94,441,524...94,479,696
G
Irs1
insulin receptor substrate 1
ISO
protein:decreased tyrosine phosphorylation, increased serine phosphorylation:gastrocnemius
RGD
PMID:19781177
RGD:6482862
NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137
G
Itga4
integrin alpha 4
ISO
protein:increased expression:neutrophil
RGD
PMID:19011162
RGD:13593535
NCBI chr 2:79,084,767...79,163,458
Ensembl chr 2:79,085,770...79,163,467
G
Itgam
integrin alpha M
exacerbates
ISO
protein:increased expression:neutrophil (rat)
RGD
PMID:9151199
RGD:329902068
NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663
G
Jak2
Janus kinase 2
treatment
ISO
RGD
PMID:24228589
RGD:10411888
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Keap1
kelch-like ECH-associated protein 1
IMP
RGD
PMID:21799073
RGD:6892955
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
G
Klkb1
kallikrein B, plasma 1
ISO
RGD
PMID:22352684
RGD:7297048
NCBI chr 8:45,719,725...45,747,872
Ensembl chr 8:45,719,726...45,747,896
G
Klrk1
killer cell lectin-like receptor subfamily K, member 1
susceptibility
IMP
associated with Gram-Negative Bacterial Infections
RGD
PMID:28087665
RGD:38676493
NCBI chr 6:129,587,286...129,600,863
Ensembl chr 6:129,587,286...129,600,827
G
Lbp
lipopolysaccharide binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22167001
NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772
G
Lcn2
lipocalin 2
exacerbates
IMP
RGD
PMID:22786765
RGD:126781712
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Lep
leptin
ISO
RGD
PMID:18575315
RGD:5128818
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lipc
lipase, hepatic
ISO
protein:decreased expression:diaphragm, heart, adipose tissue (rat)
RGD
PMID:2113037
RGD:2308797
NCBI chr 9:70,705,410...70,859,503
Ensembl chr 9:70,705,410...70,859,508
G
Lta
lymphotoxin A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22977509
NCBI chr17:35,422,141...35,424,568
Ensembl chr17:35,422,141...35,424,327
G
Ltf
lactotransferrin
ISO
RGD
PMID:23425819
RGD:7243861
NCBI chr 9:110,848,360...110,871,834
Ensembl chr 9:110,848,339...110,871,835
G
Mapk1
mitogen-activated protein kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15489642
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15489642
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mapk8
mitogen-activated protein kinase 8
treatment
ISO
RGD
PMID:14662889
RGD:126928138
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mbl2
mannose-binding lectin (protein C) 2
susceptibility
ISO
associated with Premature Birth;DNA:polymorphism:exon:
RGD
PMID:22882323
RGD:12910846
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
G
Mfn2
mitofusin 2
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:24720571
RGD:13204837
NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
G
Mif
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:9892616 PMID:17585860
RGD:4891012
NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
G
Mir143
microRNA 143
exacerbates
ISO
RGD
PMID:30546393
RGD:155883166
NCBI chr18:61,782,267...61,782,329
Ensembl chr18:61,782,267...61,782,329
G
Mir146
microRNA 146
IEP
miRNA:increased expression:myocardium, blood serum (mouse)
RGD
PMID:26048146
RGD:126925143
NCBI chr11:43,265,224...43,265,288
Ensembl chr11:43,265,224...43,265,288
G
Mir155
microRNA 155
ISO IEP
RGD
PMID:27434558 PMID:29979224
RGD:21079467 , RGD:21081538
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mir223
microRNA 223
ISO
RNA:increased expression:plasma:
RGD
PMID:24680405
RGD:21408586
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
G
Mir483
microRNA 483
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32062619
NCBI chr 7:142,208,661...142,208,733
Ensembl chr 7:142,208,661...142,208,733
G
Mir494
microRNA 494
ISO
RNA:decreased expression:plasma
RGD
PMID:31002148
RGD:155900762
NCBI chr12:109,681,752...109,681,836
Ensembl chr12:109,681,752...109,681,836
G
Mmp1a
matrix metallopeptidase 1a (interstitial collagenase)
ISO
RGD
PMID:23478082
RGD:8549749
NCBI chr 9:7,464,141...7,476,870
Ensembl chr 9:7,464,141...7,476,857
G
Mmp1b
matrix metallopeptidase 1b (interstitial collagenase)
ISO
RGD
PMID:23478082
RGD:8549749
NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
G
Mmp2
matrix metallopeptidase 2
treatment
ISO
RGD
PMID:23479197
RGD:8657110
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp9
matrix metallopeptidase 9
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16003065 PMID:23479197
RGD:8657110
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mpo
myeloperoxidase
IMP
RGD
PMID:18424617
RGD:5130966
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
mt-Cytb
cytochrome b, mitochondrial
ISO
protein:decreased expression:mitochondrion, skeletal muscle
RGD
PMID:6128308
RGD:2298978
NCBI chr MT:14,145...15,288
Ensembl chr MT:14,145...15,288
G
Mt1
metallothionein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374846
NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955
G
Mt2
metallothionein 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17374846
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
G
Mtor
mechanistic target of rapamycin kinase
ISO
RGD
PMID:20577146
RGD:10041013
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Mylk
myosin, light polypeptide kinase
ISO
RGD
PMID:16399953
RGD:1581052
NCBI chr16:34,565,569...34,822,806
Ensembl chr16:34,565,580...34,822,790
G
Ndufb8
NADH:ubiquinone oxidoreductase subunit B8
ISO
RGD
PMID:22952679
RGD:13801198
NCBI chr19:44,537,010...44,543,881
Ensembl chr19:44,537,011...44,543,879
G
Nefh
neurofilament, heavy polypeptide
severity
ISO
RGD
PMID:30677080
RGD:27226881
NCBI chr11:4,888,754...4,898,064
Ensembl chr11:4,888,754...4,898,064
G
Nefl
neurofilament, light polypeptide
disease_progression
ISO
RGD
PMID:30677080
RGD:27226881
NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
treatment
ISO
RGD
PMID:14662889
RGD:126928138
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nod2
nucleotide-binding oligomerization domain containing 2
susceptibility
ISO
DNA:missense mutations, frameshift mutation:cds:p.R702W, p.G908R, 3020_3021insC (human) mRNA:increased expression:intestine mucosa (rat)
RGD
PMID:21460759 PMID:24059417
RGD:5508752 , RGD:8547531
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
G
Nos1
nitric oxide synthase 1, neuronal
ISO
RGD
PMID:17191663
RGD:1642148
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
G
Nos2
nitric oxide synthase 2, inducible
IDA ISO
associated with lung injury CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17138957 PMID:20035746 PMID:21184738 PMID:15665729
RGD:4891414 , RGD:5147745
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nos3
nitric oxide synthase 3, endothelial cell
ISO
protein:increased expression:heart CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20035746 PMID:17999941
RGD:2292119
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Nox1
NADPH oxidase 1
ameliorates
IMP
RGD
PMID:22982050
RGD:329955362
NCBI chr X:132,987,170...133,038,455
Ensembl chr X:132,987,170...133,122,705
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
treatment
IEP ISO
protein:decreased expression:alveolar macrophage
RGD
PMID:21057058 PMID:21787473
RGD:4892317 , RGD:7174711
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Otc
ornithine transcarbamylase
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:10353541
RGD:4144069
NCBI chr X:10,118,584...10,187,275
Ensembl chr X:10,118,544...10,187,263
G
Pdcd1
programmed cell death 1
disease_progression
ISO IMP
protein:increased expression:T cell protein:increased expression:B cell,CD4T cell
RGD
PMID:30595665 PMID:27156867 PMID:29702526 PMID:29661225 PMID:19332785
RGD:40818235 , RGD:41412183 , RGD:40822808 , RGD:40818424 , RGD:40818273
NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278
G
Pdcd1lg2
programmed cell death 1 ligand 2
ISO
protein:increased expression:CD27B cell
RGD
PMID:29661225
RGD:40818424
NCBI chr19:29,388,319...29,450,327
Ensembl chr19:29,388,319...29,448,561
G
Pecam1
platelet/endothelial cell adhesion molecule 1
disease_progression
IEP
protein:increased expression:myeloid suppressor cell (mouse)
RGD
PMID:22451518
RGD:6771205
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Pgf
placental growth factor
IEP
protein:increased expression:plasma
RGD
PMID:16702604
RGD:6483601
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
IMP
RGD
PMID:20508212
RGD:6482683
NCBI chr12:32,223,128...32,258,675
Ensembl chr12:32,223,472...32,258,658
G
Pla2g4a
phospholipase A2, group IVA (cytosolic, calcium-dependent)
ISO
protein:increased activity:liver
RGD
PMID:9879654
RGD:1642481
NCBI chr 1:149,705,369...149,837,041
Ensembl chr 1:149,705,369...149,837,041
G
Plat
plasminogen activator, tissue
treatment
ISO
RGD
PMID:12000738
RGD:1598921
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Plau
plasminogen activator, urokinase
disease_progression
ISO
Pneumonia associated sepsis
RGD
PMID:21219633
RGD:4891938
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Plaur
plasminogen activator, urokinase receptor
ISO
protein:increased expression:plasma
RGD
PMID:22550400
RGD:6483789
NCBI chr 7:24,161,857...24,175,393
Ensembl chr 7:24,161,909...24,175,393
G
Ppara
peroxisome proliferator activated receptor alpha
severity
IAGP
DNA:knockout::associated with more severe disease
RGD
PMID:22089192
RGD:5562037
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
G
Ppargc1a
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
IEP
mRNA:decreased expression:skeletal muscle
RGD
PMID:20647557
RGD:6484531
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
G
Ppargc1b
peroxisome proliferative activated receptor, gamma, coactivator 1 beta
IEP
mRNA:decreased expression:skeletal muscle
RGD
PMID:20647557
RGD:6484531
NCBI chr18:61,424,516...61,533,846
Ensembl chr18:61,431,207...61,533,502
G
Ppia
peptidylprolyl isomerase A
treatment
IMP
RGD
PMID:29680745
RGD:150429626
NCBI chr11:6,365,867...6,369,817
Ensembl chr11:6,365,443...6,369,817
G
Prkcq
protein kinase C, theta
ISO
protein:decreased expression:lymphocyte
RGD
PMID:11735277
RGD:1625613
NCBI chr 2:11,176,922...11,306,033
Ensembl chr 2:11,176,919...11,306,033
G
Proc
protein C
treatment disease_progression
ISO
CTD Direct Evidence: therapeutic mRNA, protein:decreased expression:liver, plasma
CTD RGD
PMID:11820775 PMID:17556722 PMID:22940033 PMID:15241104
RGD:11100029 , RGD:11250412
NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
G
Pvt1
Pvt1 oncogene
ISO
RNA:increased expression:myocardium
RGD
PMID:30546393
RGD:155883166
NCBI chr15:61,909,835...62,132,064
Ensembl chr15:61,888,639...62,249,945
G
Rac1
Rac family small GTPase 1
ISO
mRNA:increased expression:blood serum (human)
RGD
PMID:33174038
RGD:152998912
NCBI chr 5:143,491,236...143,513,786
Ensembl chr 5:143,489,389...143,513,791
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
ISO
protein:increased expression:nucleus, lung
RGD
PMID:17626913
RGD:2298853
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Retn
resistin
ISO
protein:increased expression:serum
RGD
PMID:19545363
RGD:7207151
NCBI chr 8:3,705,770...3,709,818
Ensembl chr 8:3,705,770...3,710,110
G
Ripk3
receptor-interacting serine-threonine kinase 3
no_association ameliorates
IMP IGI
RGD
PMID:23835476 PMID:32152555 PMID:22195746
RGD:127229908 , RGD:127229919 , RGD:127229909
NCBI chr14:56,022,452...56,026,314
Ensembl chr14:56,022,452...56,026,322
G
Rpl4
ribosomal protein L4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27978524
NCBI chr 9:64,080,159...64,085,805
Ensembl chr 9:64,080,657...64,085,948
G
Rpl9
ribosomal protein L9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27978524
NCBI chr 5:65,545,707...65,548,774
Ensembl chr 5:65,545,707...65,548,787
G
Rxra
retinoid X receptor alpha
ISO
protein:altered localization:liver protein:decreased expression:liver
RGD
PMID:19008781 PMID:17483744
RGD:2317466 , RGD:1643106
NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969
G
Ryr1
ryanodine receptor 1, skeletal muscle
ISO
mRNA:increased expression:fast muscle tissue protein:decreased expression:diaphragmaticus muscle
RGD
PMID:18520643 PMID:28044347
RGD:329849107 , RGD:329849111
NCBI chr 7:28,702,765...28,824,599
Ensembl chr 7:28,702,769...28,824,604
G
S100b
S100 protein, beta polypeptide, neural
ISO
RGD
PMID:19809934
RGD:5508796
NCBI chr10:76,089,670...76,097,153
Ensembl chr10:76,089,687...76,096,993
G
Sell
selectin, lymphocyte
ISO
RGD
PMID:16026013 PMID:15677732
RGD:5685706 , RGD:5686285
NCBI chr 1:163,889,556...163,908,354
Ensembl chr 1:163,889,551...163,911,750
G
Selp
selectin, platelet
IEP
protein:increased expression:multiple
RGD
PMID:20690979
RGD:6478679
NCBI chr 1:163,942,833...163,977,595
Ensembl chr 1:163,942,833...163,977,595
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
treatment
ISO
associated with Pneumonia; protein:increased expression:plasma
RGD
PMID:19753144 PMID:12000738
RGD:4144830 , RGD:1598921
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Slc38a2
solute carrier family 38, member 2
ISO
RGD
PMID:20338592
RGD:9999218
NCBI chr15:96,585,267...96,597,609
Ensembl chr15:96,585,273...96,597,611
G
Slco1b2
solute carrier organic anion transporter family, member 1b2
ISO
mRNA:decreased expression:liver
RGD
PMID:10500057
RGD:631887
NCBI chr 6:141,575,178...141,632,372
Ensembl chr 6:141,575,244...141,632,372
G
Socs1
suppressor of cytokine signaling 1
ISO
protein:increased expression:gastrocnemius mRNA:increased expression:liver
RGD
PMID:12644450 PMID:11312157
RGD:2298924 , RGD:634751
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
G
Socs2
suppressor of cytokine signaling 2
ISO
protein:increased expression:gastrocnemius
RGD
PMID:12644450
RGD:2298924
NCBI chr10:95,219,765...95,253,176
Ensembl chr10:95,221,224...95,253,042
G
Socs3
suppressor of cytokine signaling 3
ISO
protein:increased expression:gastrocnemius mRNA:increased expression:liver
RGD
PMID:12644450 PMID:11312157
RGD:2298924 , RGD:634751
NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873
G
Sod1
superoxide dismutase 1, soluble
ISO
RGD
PMID:26266917
RGD:11035300
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sod2
superoxide dismutase 2, mitochondrial
ISO
mRNA, protein:increased expression:lung
RGD
PMID:26266917
RGD:11035300
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Sod3
superoxide dismutase 3, extracellular
ISO
RGD
PMID:26266917
RGD:11035300
NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760
G
Stat1
signal transducer and activator of transcription 1
ISO
protein:increased activity:liver, lung, small intestine
RGD
PMID:17067487
RGD:2291905
NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
G
Stat3
signal transducer and activator of transcription 3
treatment
ISO
RGD
PMID:24228589
RGD:10411888
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
G
Stat4
signal transducer and activator of transcription 4
IMP
RGD
PMID:11257135
RGD:7207876
NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
G
Stat6
signal transducer and activator of transcription 6
severity
IMP
RGD
PMID:11257135
RGD:7207876
NCBI chr10:127,478,855...127,496,856
Ensembl chr10:127,478,855...127,496,826
G
Tbx21
T-box 21
severity
ISO
RGD
PMID:25403265
RGD:38455982
NCBI chr11:96,988,833...97,006,157
Ensembl chr11:96,988,897...97,006,157
G
Tfpi
tissue factor pathway inhibitor
ISO
protein:decreased activity:plasma:
RGD
PMID:15497025
RGD:2313648
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
G
Tgfb1
transforming growth factor, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16003065
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tgfbi
transforming growth factor, beta induced
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27887929
NCBI chr13:56,757,399...56,787,172
Ensembl chr13:56,757,336...56,787,375
G
Thbd
thrombomodulin
ISO
RGD
PMID:17577447
RGD:2312462
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
G
Tlr2
toll-like receptor 2
ISO
associated with Burns;mRNA:increased expression:liver, lung, kidney associated with Liver Diseases;mRNA:increased expression:liver
RGD
PMID:14604479 PMID:12831613 PMID:19489280
RGD:2312732 , RGD:1302750 , RGD:2312497
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
ISO
associated with Sepsis;mRNA:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20624996 PMID:19489280 PMID:14604479
RGD:2312497 , RGD:2312732
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tlr6
toll-like receptor 6
ISO
mRNA:increased expression:plasma
RGD
PMID:31002148
RGD:155900762
NCBI chr 5:65,109,373...65,128,387
Ensembl chr 5:65,109,374...65,117,440
G
Tnf
tumor necrosis factor
treatment
ISO IDA
mRNA:increased expression:heart CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8741040 PMID:9806674 PMID:15489642 PMID:19695174 PMID:27488951 PMID:24055021 PMID:15665729 More...
RGD:4144094 , RGD:14975262 , RGD:7364867 , RGD:5147745
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Top2a
topoisomerase (DNA) II alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27978524
NCBI chr11:98,883,773...98,915,037
Ensembl chr11:98,883,769...98,915,015
G
Tpp2
tripeptidyl peptidase II
ISO
mRNA, protein:increased expression, increased activity:extensor digitorum longus (rat)
RGD
PMID:12147224
RGD:634435
NCBI chr 1:43,973,130...44,042,160
Ensembl chr 1:43,972,807...44,042,160
G
Trem1
triggering receptor expressed on myeloid cells 1
disease_progression treatment
ISO
mRNA:decreased expression:polymorph nuclear cell:
RGD
PMID:22809118 PMID:22147417 PMID:22996209
RGD:126925981 , RGD:127284847 , RGD:126925987
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
Tslp
thymic stromal lymphopoietin
treatment disease_progression
IMP IEP
protein:increased expression:peritoneum, plasma (mouse)
RGD
PMID:24990542 PMID:26934097
RGD:38549375 , RGD:38596335
NCBI chr18:32,948,436...32,952,852
Ensembl chr18:32,948,436...32,952,850
G
Xdh
xanthine dehydrogenase
treatment
ISO
RGD
PMID:19751566
RGD:7247648
NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
G
Xiap
X-linked inhibitor of apoptosis
ISO
ClinVar Annotator: match by term: Sepsis
ClinVar
PMID:17080092 PMID:21119115 PMID:25666262 PMID:25741868 PMID:27747465 PMID:28492532 PMID:28936583 More...
NCBI chr X:41,148,483...41,198,541
Ensembl chr X:41,148,556...41,198,533
G
C3
complement component 3
ISO
associated with Experimental Liver Cirrhosis; protein:decreased expression:serum
RGD
PMID:11349015
RGD:408395143
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Ccl2
C-C motif chemokine ligand 2
ISO
associated with Febrile Neutropenia;protein:increased expression:serum (human)
RGD
PMID:22584776
RGD:11528568
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Cebpb
CCAAT/enhancer binding protein beta
IEP
associated with alcohol use disorder;mRNA:increased expression:bone marrow (mouse)
RGD
PMID:28784931
RGD:40903040
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
G
Cfh
complement component factor h
ISO
associated with Meningococcal Infections;
RGD
PMID:22104107
RGD:7364945
NCBI chr 1:140,013,593...140,111,149
Ensembl chr 1:140,012,446...140,111,502
G
Cish
cytokine inducible SH2-containing protein
susceptibility
ISO
ClinVar Annotator: match by term: Bacteremia, susceptibility to, 2 CTD Direct Evidence: marker/mechanism
ClinVar CTD OMIM
PMID:20484391
NCBI chr 9:107,173,858...107,179,983
Ensembl chr 9:107,173,225...107,179,983
G
Cpb2
carboxypeptidase B2
ISO
protein:decreased activity:plasma
RGD
PMID:17911187
RGD:2313646
NCBI chr14:75,479,727...75,520,995
Ensembl chr14:75,479,727...75,520,995
G
Crp
C-reactive protein, pentraxin-related
ISO
protein:increased expression:serum:
RGD
PMID:18443549
RGD:9491402
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Csf2
colony stimulating factor 2 (granulocyte-macrophage)
treatment
IDA
RGD
PMID:2192004
RGD:10449532
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
G
Fcgr3
Fc receptor, IgG, low affinity III
ISO
associated with Pneumonia;DNA:SNP: :p.H131R (rs1801274) (human)
RGD
PMID:21317643
RGD:5147986
NCBI chr 1:170,878,738...170,893,477
Ensembl chr 1:170,878,743...170,892,504
G
Hmgcr
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
severity
ISO
RGD
PMID:11565076
RGD:5508478
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
G
Icam1
intercellular adhesion molecule 1
IEP
mRNA:increased expression:lung,thymus,spleen:
RGD
PMID:24891762
RGD:11354979
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Il17a
interleukin 17A
ISO
associated with Respiratory Distress Syndrome, Adult; protein:increased expression:serum
RGD
PMID:21062445
RGD:5128683
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il27
interleukin 27
ISO
protein:increased expression:blood serum (human)
RGD
PMID:26514771
RGD:126790515
NCBI chr 7:126,188,181...126,194,197
Ensembl chr 7:126,188,182...126,194,113
G
Itih4
inter alpha-trypsin inhibitor, heavy chain 4
IEP
protein:increased expression:liver, serum
RGD
PMID:33348064
RGD:40907057
NCBI chr14:30,608,433...30,623,943
Ensembl chr14:30,608,433...30,624,310
G
Mapkapk3
mitogen-activated protein kinase-activated protein kinase 3
ISO
ClinVar Annotator: match by term: Bacteremia, susceptibility to, 2
ClinVar
PMID:20484391
NCBI chr 9:107,132,125...107,167,082
Ensembl chr 9:107,132,126...107,167,076
G
Mbl2
mannose-binding lectin (protein C) 2
treatment
ISO
associated with Multiple Myeloma:DNA:polymorphism:exon:
RGD
PMID:16953214
RGD:11530047
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
G
Nod2
nucleotide-binding oligomerization domain containing 2
severity
ISO
associated with Staphylococcal Infections;
RGD
PMID:24086711
RGD:13204726
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
G
Plat
plasminogen activator, tissue
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1430592
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Plaur
plasminogen activator, urokinase receptor
severity
ISO
RGD
PMID:21332843
RGD:6483799
NCBI chr 7:24,161,857...24,175,393
Ensembl chr 7:24,161,909...24,175,393
G
Serpinc1
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1
treatment
ISO
RGD
PMID:2679067
RGD:11035251
NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433
G
Sod2
superoxide dismutase 2, mitochondrial
IEP
mRNA:increased expression:liver:
RGD
PMID:24253037
RGD:26923958
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Tirap
toll-interleukin 1 receptor (TIR) domain-containing adaptor protein
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Bacteremia, susceptibility to, 1
CTD ClinVar OMIM
PMID:16991088 PMID:17322885 PMID:18305471 PMID:25741868
NCBI chr 9:35,095,687...35,111,587
Ensembl chr 9:35,095,847...35,111,587
G
Tlr4
toll-like receptor 4
susceptibility
ISO
DNA:polymorphisms:cds:p.D299G, T399I (human)
RGD
PMID:18180796
RGD:4144194
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Trem1
triggering receptor expressed on myeloid cells 1
treatment ameliorates exacerbates
ISO IMP
associated with bacterial pneumonia
RGD
PMID:21507332 PMID:16960786 PMID:17230441
RGD:126925982 , RGD:127229902 , RGD:126928125
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
Cd1d1
CD1d1 antigen
ameliorates
IMP
associated with endotoxemia
RGD
PMID:32154791
RGD:127345119
NCBI chr 3:86,903,141...86,919,665
Ensembl chr 3:86,903,141...86,906,748
G
Ephb2
Eph receptor B2
exacerbates
IMP
RGD
PMID:33685996
RGD:127229905
NCBI chr 4:136,374,850...136,563,637
Ensembl chr 4:136,374,850...136,563,299
G
Ace2
angiotensin converting enzyme 2
susceptibility
ISO
DNA:SNP:intron 1: C>T
RGD
PMID:20117248
RGD:40818420
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
G
Aqp4
aquaporin 4
disease_progression
IEP
protein:increased expression:astrocyte:
RGD
PMID:21904632
RGD:8698661
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
G
Cast
calpastatin
IEP
protein:increased express:brain
RGD
PMID:16236382
RGD:5509817
NCBI chr13:74,840,485...74,956,993
Ensembl chr13:74,840,487...74,956,929
G
Cd36
CD36 molecule
IMP
RGD
PMID:17367535
RGD:6893527
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
G
Clec12a
C-type lectin domain family 12, member a
ameliorates
IMP
RGD
PMID:31269448
RGD:41412201
NCBI chr 6:129,327,207...129,342,266
Ensembl chr 6:129,319,654...129,342,266
G
Il1rl1
interleukin 1 receptor-like 1
treatment
IMP
RGD
PMID:25682948
RGD:40400741
NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575
G
Il33
interleukin 33
treatment
IDA IEP
protein:increased expression:brain
RGD
PMID:25659095 PMID:25682948
RGD:39938955 , RGD:40400741
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
Jak3
Janus kinase 3
IMP
RGD
PMID:22363534
RGD:11531103
NCBI chr 8:72,129,027...72,143,221
Ensembl chr 8:72,128,940...72,143,219
G
Lta
lymphotoxin A
IMP
RGD
PMID:12021316
RGD:10449455
NCBI chr17:35,422,141...35,424,568
Ensembl chr17:35,422,141...35,424,327
G
Nrg1
neuregulin 1
treatment
IEP ISO
mRNA, protein:increased expression:cerebral cortex (mouse) human protein in a mouse model
RGD
PMID:29636063 PMID:24433482
RGD:39456084 , RGD:39456102
NCBI chr 8:32,299,493...33,381,858
Ensembl chr 8:32,304,579...33,374,825 Ensembl chr 8:32,304,579...33,374,825
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
IMP
RGD
PMID:25775137
RGD:38599200
NCBI chr12:32,223,128...32,258,675
Ensembl chr12:32,223,472...32,258,658
G
Prkaa2
protein kinase, AMP-activated, alpha 2 catalytic subunit
IEP
mRNA:decreased expression:brain (mouse)
RGD
PMID:29107705
RGD:39456137
NCBI chr 4:104,886,846...104,967,095
Ensembl chr 4:104,887,071...104,967,087
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
IMP
RGD
PMID:12228317
RGD:5131158
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
G
Abcb11
ATP-binding cassette, sub-family B member 11
ISO
RGD
PMID:9828229
RGD:1598596
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:26977098
RGD:11041000
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
ISO EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20300455 PMID:9828229
RGD:1598596
NCBI chr 5:8,848,147...8,916,314
Ensembl chr 5:8,848,147...8,916,315
G
Abcc2
ATP-binding cassette, sub-family member 2
ISO
RGD
PMID:16572733
RGD:1598611
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
G
Abcc8
ATP-binding cassette, sub-family C member 8
ISO
RGD
PMID:17285300
RGD:2301914
NCBI chr 7:45,753,952...45,829,441
Ensembl chr 7:45,753,947...45,829,457
G
Ace
angiotensin I converting enzyme
ISO
associated with Hemorrhage;protein:decreased activity:plasma (rat)
RGD
PMID:3028670
RGD:8142370
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Ache
acetylcholinesterase
ISO
RGD
PMID:17657467
RGD:5688055
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Actc1
actin, alpha, cardiac muscle 1
ISO
RGD
PMID:11680626
RGD:1598729
NCBI chr 2:113,877,763...113,883,356
Ensembl chr 2:113,877,763...113,884,029
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
protein:increased expression:plasma, spleen
RGD
PMID:23025351
RGD:9681752
NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
associated with Obesity
RGD
PMID:23838384
RGD:8695926
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adipor2
adiponectin receptor 2
severity
ISO
associated with obesity;mRNA:decreased expression:liver (rat)
RGD
PMID:23838384
RGD:8695926
NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665
G
Adra2a
adrenergic receptor, alpha 2a
onset
ISO
mRNA:increased expression:spleen
RGD
PMID:20302880
RGD:6480487
NCBI chr19:54,033,690...54,037,413
Ensembl chr19:54,032,582...54,037,413
G
Agtr1a
angiotensin II receptor, type 1a
ISO
protein:increased expression:kidney
RGD
PMID:16725227
RGD:6903849
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
G
Agtr2
angiotensin II receptor, type 2
ISO
protein:decreased expression:kidney
RGD
PMID:16725227
RGD:6903849
NCBI chr X:21,350,863...21,355,072
Ensembl chr X:21,350,783...21,355,403
G
Ahr
aryl-hydrocarbon receptor
severity
IMP
RGD
PMID:24930766
RGD:39939032
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Akp3
alkaline phosphatase 3, intestine, not Mn requiring
IMP
RGD
PMID:23569246
RGD:14349049
NCBI chr 1:87,052,676...87,056,450
Ensembl chr 1:87,052,695...87,055,634
G
Akt1
thymoma viral proto-oncogene 1
ISO
RGD
PMID:22824368
RGD:38676479
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Aldoa
aldolase A, fructose-bisphosphate
ISO
RGD
PMID:16930621
RGD:1599054
NCBI chr 7:126,394,406...126,399,537
Ensembl chr 7:126,394,406...126,399,923
G
Alox5
arachidonate 5-lipoxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15328337
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
G
Apoa1
apolipoprotein A-I
treatment
ISO
RGD
PMID:18593575 PMID:23227448
RGD:7241573 , RGD:7241868
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Apob
apolipoprotein B
ISO
RGD
PMID:16719989
RGD:1599165
NCBI chr12:8,027,629...8,066,839
Ensembl chr12:8,027,648...8,066,835
G
Apoe
apolipoprotein E
ISO
rat model treated with human protein
RGD
PMID:9153287
RGD:6904216
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
Asl
argininosuccinate lyase
ISO
RGD
PMID:10652239
RGD:1599265
NCBI chr 5:130,040,099...130,053,222
Ensembl chr 5:130,040,099...130,058,088
G
Ass1
argininosuccinate synthetase 1
ISO
RGD
PMID:10652239
RGD:1599265
NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
G
Atf2
activating transcription factor 2
treatment
ISO
protein:increased expression, increased activity:small intestine mucosa
RGD
PMID:21641970 PMID:24312512
RGD:5135029 , RGD:10047418
NCBI chr 2:73,646,853...73,723,094
Ensembl chr 2:73,646,853...73,722,983
G
Atp5f1a
ATP synthase F1 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr18:77,861,468...77,870,569
Ensembl chr18:77,861,429...77,870,569
G
Bax
BCL2-associated X protein
ISO
mRNA:increased expression:diaphragm
RGD
PMID:23940949
RGD:10054120
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bche
butyrylcholinesterase
ISO
RGD
PMID:17657467
RGD:5688055
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
G
Bcl2
B cell leukemia/lymphoma 2
ISO
mRNA:decreased expression:diaphragm
RGD
PMID:23940949
RGD:10054120
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
C5ar1
complement component 5a receptor 1
ISO
mRNA:increased expression:lung
RGD
PMID:9272704
RGD:70679
NCBI chr 7:15,980,668...15,993,465
Ensembl chr 7:15,980,668...15,993,465
G
Casp1
caspase 1
ISO
RGD
PMID:17384935
RGD:2315892
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
G
Casp3
caspase 3
ISO
mRNA:increased expression:diaphragm
RGD
PMID:23940949
RGD:10054120
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp7
caspase 7
IMP
RGD
PMID:19168786
RGD:5684539
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
G
Casp9
caspase 9
treatment
ISO
RGD
PMID:23214195
RGD:10400903
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cbs
cystathionine beta-synthase
severity
IMP IEP ISO
Protein:increased expression:spleen, lung (mouse) mRNA:increased expression:liver (rat)
RGD
PMID:27748832 PMID:27748832 PMID:24702258 PMID:16100527
RGD:40903019 , RGD:40903019 , RGD:40903035 , RGD:40903049
NCBI chr17:31,831,602...31,856,170
Ensembl chr17:31,827,868...31,856,212
G
Ccl2
C-C motif chemokine ligand 2
ISO
protein:increased expression:plasma
RGD
PMID:19060786
RGD:2307004
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased expression:plasma
RGD
PMID:16215387
RGD:2307171
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Ccr1
C-C motif chemokine receptor 1
IMP
RGD
PMID:17016504
RGD:5688178
NCBI chr 9:123,762,163...123,768,729
Ensembl chr 9:123,762,161...123,768,729
G
Cd14
CD14 antigen
ISO
protein:increased expression:liver, endothelial cell of sinusoid
RGD
PMID:12046090
RGD:724637
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
G
Cd40
CD40 antigen
IDA
protein:decreased nitrosylation:macrophage
RGD
PMID:20473113
RGD:5490974
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cebpb
CCAAT/enhancer binding protein beta
treatment
ISO IDA
RGD
PMID:15192048 PMID:14659593
RGD:1625687 , RGD:40903034
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
G
Cps1
carbamoyl-phosphate synthetase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr 1:67,151,294...67,270,426
Ensembl chr 1:67,162,185...67,270,418
G
Cs
citrate synthase
ISO
protein:increased expression:gastrocnemius
RGD
PMID:25674200
RGD:329337350
NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
G
Csf3
colony stimulating factor 3 (granulocyte)
treatment
ISO
RGD
PMID:9514298
RGD:11039535
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
protein:increased expression:atrium endocardium
RGD
PMID:19282612
RGD:4891965
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP
mRNA:increased expression:multiple organs
RGD
PMID:9766630
RGD:5135254
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl2
C-X-C motif chemokine ligand 2
IEP
mRNA:increased expression:multiple organs
RGD
PMID:9766630
RGD:5135254
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cxcl5
C-X-C motif chemokine ligand 5
IEP
mRNA:increased expression:multiple organs
RGD
PMID:9766630
RGD:5135254
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
G
Edn1
endothelin 1
ISO
mRNA, protein:increased expression:liver (rat)
RGD
PMID:11206318
RGD:8662297
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Ep300
E1A binding protein p300
ISO
associated with Kidney Reperfusion Injury; protein:altered localization:kidney (rat)
RGD
PMID:23936185
RGD:7257563
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
G
Ephx2
epoxide hydrolase 2, cytoplasmic
IMP
RGD
PMID:19154430
RGD:5688360
NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
G
Epo
erythropoietin
treatment
ISO
RGD
PMID:23214195
RGD:10400903
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
F12
coagulation factor XII (Hageman factor)
ISO
RGD
PMID:11092686
RGD:7394782
NCBI chr13:55,565,771...55,574,617
Ensembl chr13:55,565,771...55,574,606
G
F2
coagulation factor II
treatment severity
ISO
associated with liver cirrhosis;protein:increased expression:blood plasma (human) associated with liver cirrhosis;protein:increased expression:plasma (human)
RGD
PMID:21396682 PMID:10604885 PMID:7615203 PMID:10887118 PMID:9863491 PMID:25396762 PMID:22227956 PMID:20519137 More...
RGD:5147765 , RGD:40818436 , RGD:14974253 , RGD:40818427 , RGD:14401592 , RGD:10449434 , RGD:6893482 , RGD:5147779
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
F3
coagulation factor III
treatment
ISO IMP
associated with Protein C Deficiency
RGD
PMID:21396682 PMID:20858853 PMID:8956768
RGD:5147765 , RGD:11341685 , RGD:11340208
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
F5
coagulation factor V
ISO
RGD
PMID:11092686
RGD:7394782
NCBI chr 1:163,979,396...164,048,539
Ensembl chr 1:163,979,407...164,047,846
G
F7
coagulation factor VII
treatment
ISO IMP
RGD
PMID:11092686 PMID:16378835
RGD:7394782 , RGD:11041650
NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
G
F8
coagulation factor VIII
ISO
RGD
PMID:11092686
RGD:7394782
NCBI chr X:74,213,950...74,426,342
Ensembl chr X:74,216,321...74,426,221
G
Fas
Fas cell surface death receptor
ISO
mRNA, protein:increased expression:spleen (rat)
RGD
PMID:20428798
RGD:8662930
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fga
fibrinogen alpha chain
treatment
ISO
RGD
PMID:19295478
RGD:11040925
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
G
Foxp3
forkhead box P3
ISO
protein:increased expression:intestinal mucosa
RGD
PMID:19998507
RGD:38455980
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
G
Gch1
GTP cyclohydrolase 1
treatment
ISO
mRNA:increased expression:lung associated with liver cirrhosis
RGD
PMID:9388472 PMID:16845913 PMID:14647062
RGD:329961576 , RGD:401793756 , RGD:401700399
NCBI chr14:47,391,352...47,426,870
Ensembl chr14:47,391,352...47,426,870
G
Gfer
growth factor, augmenter of liver regeneration
ISO
RGD
PMID:23073658
RGD:9685733
NCBI chr17:24,912,164...24,915,065
Ensembl chr17:24,912,161...24,915,503
G
Ghr
growth hormone receptor
ISO
mRNA:decreased expression:liver
RGD
PMID:12654216 PMID:12217886
RGD:2307380 , RGD:625688
NCBI chr15:3,347,237...3,612,834
Ensembl chr15:3,347,242...3,612,974
G
Gpt
glutamic pyruvic transaminase, soluble
treatment
ISO
RGD
PMID:25514429
RGD:401717525
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Gsr
glutathione reductase
treatment
ISO
RGD
PMID:25469663
RGD:10401928
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Hmgb1
high mobility group box 1
ISO
protein:increased expression:heart, serum
RGD
PMID:18503231
RGD:10402065
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Hmox1
heme oxygenase 1
treatment
ISO
RGD
PMID:21396999
RGD:10755715
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hsf1
heat shock factor 1
treatment
ISO
RGD
PMID:25571843
RGD:10402404
NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113
G
Hspa9
heat shock protein 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410
G
Hspd1
heat shock protein 1 (chaperonin)
ISO
mRNA, protein:increased expression:medulla oblongata CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16741687 PMID:16675490
RGD:1624232
NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased expression:lung (rat)
RGD
PMID:19776691
RGD:4145502
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ido1
indoleamine 2,3-dioxygenase 1
IMP
RGD
PMID:24930766 PMID:28077574
RGD:39939032 , RGD:39939117
NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
G
Ido2
indoleamine 2,3-dioxygenase 2
IMP
RGD
PMID:24930766
RGD:39939032
NCBI chr 8:25,021,908...25,066,430
Ensembl chr 8:25,021,908...25,066,349
G
Ifng
interferon gamma
ISO
protein:increased expression:serum:
RGD
PMID:9195172
RGD:10755747
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Igf1
insulin-like growth factor 1
ISO
mRNA, protein:decreased expression:liver, serum
RGD
PMID:18492809 PMID:12217886
RGD:10402757 , RGD:625688
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igfals
insulin-like growth factor binding protein, acid labile subunit
ISO
RGD
PMID:12217886
RGD:625688
NCBI chr17:25,096,818...25,100,985
Ensembl chr17:25,084,971...25,100,984
G
Igfbp1
insulin-like growth factor binding protein 1
ISO
RGD
PMID:12217886
RGD:625688
NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546
G
Igfbp3
insulin-like growth factor binding protein 3
ISO
mRNA, protein:decreased expression:liver, serum
RGD
PMID:18492809
RGD:10402757
NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923
G
Igfbp5
insulin-like growth factor binding protein 5
ISO
RGD
PMID:12217886
RGD:625688
NCBI chr 1:72,897,224...72,914,024
Ensembl chr 1:72,897,091...72,914,043
G
Il10
interleukin 10
treatment
IEP
RGD
PMID:28664613 PMID:27943364
RGD:14975137 , RGD:14975170
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il13
interleukin 13
treatment
ISO
RGD
PMID:10674721
RGD:8549626
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il1a
interleukin 1 alpha
IEP ISO
protein:increased expression:plasma
RGD
PMID:9636192 PMID:22426124
RGD:6907109 , RGD:7794786
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
ISO
protein:increased expression:plasma
RGD
PMID:17201737
RGD:1626625
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
mRNA:increased expression:lung, spleen, liver (rat)
RGD
PMID:1385928 PMID:8855299
RGD:8551846 , RGD:11522760
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il6
interleukin 6
ISO
associated with Diabetes Mellitus, Experimental; Protein:increased expression:extracellular space (rat) protein:increased expression:serum (rat)
RGD
PMID:19449282 PMID:22227956 PMID:21396682
RGD:2307179 , RGD:6893482 , RGD:5147765
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Irak3
interleukin-1 receptor-associated kinase 3
ISO
mRNA, protein:increased expression:blood (human)
RGD
PMID:17982103
RGD:36049802
NCBI chr10:119,977,553...120,038,035
Ensembl chr10:119,977,553...120,038,035
G
Irs1
insulin receptor substrate 1
IDA
protein:increased tyrosine nitration, decreased tyrosine phosphorylation:skeletal muscle
RGD
PMID:21206533
RGD:6483008
NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137
G
Itga2b
integrin alpha 2b
ISO
RGD
PMID:15280099
RGD:2316360
NCBI chr11:102,344,134...102,360,570
Ensembl chr11:102,344,123...102,360,948
G
Itgb3
integrin beta 3
ISO
RGD
PMID:15280099
RGD:2316360
NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
G
Keap1
kelch-like ECH-associated protein 1
IMP
RGD
PMID:22609006
RGD:6892951
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
G
Lbp
lipopolysaccharide binding protein
treatment
ISO IMP
mRNA:increased expression:hepatocyte
RGD
PMID:8418776 PMID:8593028 PMID:16307218
RGD:9685191 , RGD:9685196 , RGD:9685193
NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772
G
Lcn2
lipocalin 2
IEP
mRNA:increased expression:brain,liver
RGD
PMID:21943033
RGD:126779582
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Map2
microtubule-associated protein 2
IEP
mRNA, protein:decreased expression:neuron
RGD
PMID:21421895
RGD:6483086
NCBI chr 1:66,214,337...66,481,742
Ensembl chr 1:66,214,432...66,481,742
G
Mapk14
mitogen-activated protein kinase 14
treatment
ISO
protein:increased activity:small intestine mucosa
RGD
PMID:21641970 PMID:24312512
RGD:5135029 , RGD:10047418
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
G
Mapk8
mitogen-activated protein kinase 8
ISO
protein:increased phophorylation:hippocampus (rat)
RGD
PMID:12207162
RGD:150340687
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mc4r
melanocortin 4 receptor
ISO
mRNA:increased expression:paraventricular nucleus (rat)
RGD
PMID:21343543
RGD:6484214
NCBI chr18:66,990,776...66,993,558
Ensembl chr18:66,990,775...66,993,577
G
Mif
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
ISO
protein:increased expression:plasma
RGD
PMID:16601957
RGD:1641983
NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
G
Mir146
microRNA 146
treatment
IEP
miRNA:increased expression:spleen (mouse)
RGD
PMID:30867482
RGD:34888227
NCBI chr11:43,265,224...43,265,288
Ensembl chr11:43,265,224...43,265,288
G
Mir155
microRNA 155
treatment
IEP
associated with familial hyperlipidemia
RGD
PMID:28970282 PMID:28264607 PMID:29079998 PMID:29979224
RGD:21079445 , RGD:24922204 , RGD:21081539 , RGD:21081538
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mme
membrane metallo endopeptidase
severity
ISO
RGD
PMID:11078421
RGD:13801040
NCBI chr 3:63,202,632...63,291,134
Ensembl chr 3:63,148,958...63,293,451
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:17083784
RGD:2290426
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
G
Mt2
metallothionein 2
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:22100509
RGD:6483852
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
G
Mt3
metallothionein 3
ISO
RGD
PMID:12135776
RGD:10412330
NCBI chr 8:94,879,235...94,880,776
Ensembl chr 8:94,879,235...94,880,774
G
Muc2
mucin 2
ISO
RGD
PMID:19099858
RGD:7349370
NCBI chr 7:141,276,583...141,308,428
Ensembl chr 7:141,276,583...141,308,430
G
Myh6
myosin, heavy polypeptide 6, cardiac muscle, alpha
ISO
RGD
PMID:7874842
RGD:12792976
NCBI chr14:55,179,378...55,205,553
Ensembl chr14:55,179,378...55,204,384
G
Myh7
myosin, heavy polypeptide 7, cardiac muscle, beta
ISO
RGD
PMID:7874842
RGD:12792976
NCBI chr14:55,208,141...55,232,083
Ensembl chr14:55,208,141...55,232,083
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
treatment
ISO
RGD
PMID:26646455
RGD:42722616
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
exacerbates treatment
IMP IEP
RGD
PMID:19098124 PMID:10229101
RGD:126908017 , RGD:126928139
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nos2
nitric oxide synthase 2, inducible
ISO
mRNA, protein:increased expression:intestine CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12620498 PMID:16787348 PMID:20519137
RGD:4891470 , RGD:5147779
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nos3
nitric oxide synthase 3, endothelial cell
ISO
protein:increased expression:aorta (rat)
RGD
PMID:10462376
RGD:7794732
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Npy
neuropeptide Y
treatment
ISO
RGD
PMID:15342191
RGD:1580787
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
ISO
RGD
PMID:15640646
RGD:4892561
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
G
Otc
ornithine transcarbamylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr X:10,118,584...10,187,275
Ensembl chr X:10,118,544...10,187,263
G
Pck1
phosphoenolpyruvate carboxykinase 1, cytosolic
ISO
RGD
PMID:19268478 PMID:12217886
RGD:10427879 , RGD:625688
NCBI chr 2:172,994,866...173,001,067
Ensembl chr 2:172,994,841...173,001,066
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
ISO
mRNA,protein:decreased expression,decreased activity:liver:
RGD
PMID:19268478
RGD:10427879
NCBI chr14:55,777,721...55,787,477
Ensembl chr14:55,777,723...55,788,699
G
Pcsk1
proprotein convertase subtilisin/kexin type 1
ISO
RGD
PMID:16337011
RGD:6483567
NCBI chr13:75,237,407...75,282,980
Ensembl chr13:75,237,945...75,282,980
G
Pcsk2
proprotein convertase subtilisin/kexin type 2
ISO
RGD
PMID:16337011
RGD:6483567
NCBI chr 2:143,388,053...143,658,204
Ensembl chr 2:143,388,076...143,658,205
G
Pecam1
platelet/endothelial cell adhesion molecule 1
IMP
RGD
PMID:22119535
RGD:6771174
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Pf4
platelet factor 4
treatment
ISO
RGD
PMID:20601223
RGD:329901905
NCBI chr 5:90,920,362...90,921,242
Ensembl chr 5:90,920,294...90,921,242
G
Pgf
placental growth factor
IEP
protein:increased expression:multiple
RGD
PMID:16702604
RGD:6483601
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Pla2g7
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
ISO
protein:increased expression: :
RGD
PMID:10748027
RGD:7248791
NCBI chr17:43,879,009...43,923,093
Ensembl chr17:43,878,989...43,923,092
G
Plat
plasminogen activator, tissue
treatment
ISO
RGD
PMID:9091588
RGD:11541073
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Pparg
peroxisome proliferator activated receptor gamma
ISO
protein:increased expression:small intestine mucosa
RGD
PMID:21641970
RGD:5135029
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Prkaa1
protein kinase, AMP-activated, alpha 1 catalytic subunit
IEP
mRNA:decreased expression:epididymal fat pad
RGD
PMID:20421294
RGD:6484543
NCBI chr15:5,172,641...5,211,380
Ensembl chr15:5,173,343...5,211,380
G
Prkn
parkin RBR E3 ubiquitin protein ligase
IEP
protein:increased expression:liver, mitochondrion (mouse)
RGD
PMID:28615325
RGD:13432559
NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248
G
Proc
protein C
treatment
ISO
RGD
PMID:18205901 PMID:23170801
RGD:11100030 , RGD:11100034
NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
G
Ptafr
platelet-activating factor receptor
treatment
ISO
RGD
PMID:2178565
RGD:10041063
NCBI chr 4:132,291,378...132,309,994
Ensembl chr 4:132,291,378...132,309,994
G
Ptger4
prostaglandin E receptor 4 (subtype EP4)
ISO
protein:increased expression:paraventricular hypothalamic nucleus parvicellular division (rat)
RGD
PMID:11058222
RGD:10043329
NCBI chr15:5,262,880...5,273,668
Ensembl chr15:5,236,142...5,273,668
G
Ptgis
prostaglandin I2 (prostacyclin) synthase
treatment
ISO
RGD
PMID:11076704
RGD:401960076
NCBI chr 2:167,045,114...167,095,069
Ensembl chr 2:167,033,725...167,082,524
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:21641970
RGD:5135029
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ren1
renin 1 structural
IEP ISO
protein:increased activity:blood plasma (mouse) protein:increased activity:blood plasma (rat)
RGD
PMID:30027346 PMID:16512638
RGD:125097481 , RGD:125097499
NCBI chr 1:133,278,412...133,288,058
Ensembl chr 1:133,278,248...133,288,063
G
Serpinc1
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1
treatment
ISO
RGD
PMID:16457847 PMID:21396682 PMID:20519137 PMID:15995859
RGD:1599326 , RGD:5147765 , RGD:5147779 , RGD:1599332
NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
treatment
ISO
RGD
PMID:21396682 PMID:25396762
RGD:5147765 , RGD:10449434
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Serpinf1
serine (or cysteine) peptidase inhibitor, clade F, member 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:12386642
RGD:36174005
NCBI chr11:75,300,855...75,313,449
Ensembl chr11:75,300,595...75,313,527
G
Serping1
serine (or cysteine) peptidase inhibitor, clade G, member 1
treatment
ISO
RGD
PMID:18652771
RGD:8661643
NCBI chr 2:84,595,704...84,605,748
Ensembl chr 2:84,595,731...84,605,788
G
Slc18a3
solute carrier family 18 (vesicular monoamine), member 3
ISO
protein:decreased expression:parietal cortex
RGD
PMID:17306796
RGD:5686693
NCBI chr14:32,184,394...32,186,807
Ensembl chr14:32,184,395...32,186,807
G
Slc22a1
solute carrier family 22 (organic cation transporter), member 1
treatment
ISO
RGD
PMID:18313662
RGD:7243881
NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
G
Slc22a2
solute carrier family 22 (organic cation transporter), member 2
treatment
ISO
RGD
PMID:18313662
RGD:7243881
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
G
Slc38a3
solute carrier family 38, member 3
ISO
RGD
PMID:20036385
RGD:9999227
NCBI chr 9:107,528,353...107,546,167
Ensembl chr 9:107,527,833...107,546,729
G
Slc38a5
solute carrier family 38, member 5
ISO
RGD
PMID:20036385
RGD:9999227
NCBI chr X:8,137,620...8,146,418
Ensembl chr X:8,137,372...8,146,418
G
Slc7a5
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5
ISO
RGD
PMID:26337286
RGD:151361133
NCBI chr 8:122,607,885...122,634,425
Ensembl chr 8:122,607,889...122,634,433
G
Slpi
secretory leukocyte peptidase inhibitor
ISO
RGD
PMID:25466948
RGD:9999425
NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015
G
Socs1
suppressor of cytokine signaling 1
IEP
mRNA:increased expression:liver, skeletal muscle
RGD
PMID:15169905
RGD:2298923
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
G
Socs3
suppressor of cytokine signaling 3
IEP ISO
mRNA:increased expression:liver, skeletal muscle
RGD
PMID:15169905 PMID:12217886
RGD:2298923 , RGD:625688
NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873
G
Sod2
superoxide dismutase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16741687
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Sparc
secreted acidic cysteine rich glycoprotein
ISO
mRNA, protein:decreased expression:kidney
RGD
PMID:10703670
RGD:2300026
NCBI chr11:55,284,985...55,310,906
Ensembl chr11:55,285,326...55,314,009
G
Stat5b
signal transducer and activator of transcription 5B
ISO
protein:decreased tyrosine phosphorylation:liver
RGD
PMID:17327369
RGD:1601383
NCBI chr11:100,671,557...100,741,407
Ensembl chr11:100,671,557...100,741,550
G
Tbxa2r
thromboxane A2 receptor
ISO
RGD
PMID:15647606 PMID:2580129
RGD:1601450 , RGD:11059531
NCBI chr10:81,164,102...81,171,008
Ensembl chr10:81,164,565...81,171,006
G
Tbxas1
thromboxane A synthase 1, platelet
ISO
RGD
PMID:15647606
RGD:1601450
NCBI chr 6:38,817,897...39,061,524
Ensembl chr 6:38,852,338...39,061,519
G
Tdo2
tryptophan 2,3-dioxygenase
severity
IMP
RGD
PMID:24930766
RGD:39939032
NCBI chr 3:81,865,719...81,883,035
Ensembl chr 3:81,864,397...81,883,509
G
Tfpi
tissue factor pathway inhibitor
treatment
ISO
RGD
PMID:17537762
RGD:11062086
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
G
Thbd
thrombomodulin
ISO IEP
mRNA:decreased expression:endothelial cell
RGD
PMID:12611420 PMID:20348393 PMID:19487933
RGD:1601652 , RGD:5685037 , RGD:5684988
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
G
Timp3
tissue inhibitor of metalloproteinase 3
ISO
RGD
PMID:17083784
RGD:2290426
NCBI chr10:86,136,276...86,185,369
Ensembl chr10:86,136,236...86,185,370
G
Tlr2
toll-like receptor 2
treatment
ISO
RGD
PMID:22172266
RGD:7241094
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr4
toll-like receptor 4
treatment disease_progression
ISO IEP IMP
mRNA:increased expression:liver:
RGD
PMID:22172266 PMID:23977376 PMID:23977376
RGD:7241094 , RGD:14697731 , RGD:14697731
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tnf
tumor necrosis factor
treatment
ISO IEP
protein:increased expression:plasma XCO:0000822 JTE-607 associated with liver cirrhosis protein:increased expression:plasma (rat)
RGD
PMID:17324147 PMID:10493164 PMID:15242491 PMID:18078960 PMID:8283134 PMID:12813371 PMID:21396682 PMID:20519137 More...
RGD:4891465 , RGD:40903016 , RGD:38501090 , RGD:15023464 , RGD:14995443 , RGD:14995427 , RGD:5147765 , RGD:5147779
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Trem1
triggering receptor expressed on myeloid cells 1
treatment
IEP ISO
RGD
PMID:21507332 PMID:15585833
RGD:126925982 , RGD:126928122
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
Vcam1
vascular cell adhesion molecule 1
ISO
mRNA:increased expression:brain:
RGD
PMID:20061033
RGD:7240511
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
G
Vwf
Von Willebrand factor
ISO
protein:increased expression:endothelial cell:
RGD
PMID:2650559
RGD:11079230
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
G
Gch1
GTP cyclohydrolase 1
treatment
ISO
RGD
PMID:8602831
RGD:329961578
NCBI chr14:47,391,352...47,426,870
Ensembl chr14:47,391,352...47,426,870
G
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A
treatment
ISO
RGD
PMID:19318092
RGD:401901206
NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
G
Cd274
CD274 antigen
treatment
IMP
RGD
PMID:23663657
RGD:40818234
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
G
Pdcd1
programmed cell death 1
treatment
IMP IEP
protein:increased expression:CD4 Tcell, CD8 Tcell:
RGD
PMID:23663657 PMID:23663657
RGD:40818234 , RGD:40818234
NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
treatment susceptibility
ISO
DNA:SNP: :c3435C>T(human) DNA:hypermethylation:promoter DNA:SNPs,haplotype: :rs2032582, rs1128503 (human) DNA:haplotype: :1236C>T, 2677G>T,3435C>T (human)
RGD
PMID:28934955 PMID:19331170 PMID:28422980 PMID:17015054
RGD:39456120 , RGD:39457680 , RGD:39457679 , RGD:39456123
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Ace
angiotensin I converting enzyme
severity
IMP
RGD
PMID:31234939
RGD:39939120
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Ackr1
atypical chemokine receptor 1 (Duffy blood group)
ISO
ClinVar Annotator: match by term: Plasmodium vivax, resistance to CTD Direct Evidence: marker/mechanism
ClinVar CTD OMIM
PMID:7663520 PMID:8547665 PMID:8651934 PMID:10570183 PMID:10791881 PMID:17304246 PMID:18179887 PMID:18621010 PMID:19180233 PMID:19620399 PMID:20932074 More...
NCBI chr 1:173,159,457...173,161,079
Ensembl chr 1:173,159,453...173,161,317
G
Aicda
activation-induced cytidine deaminase
IEP
protein:increased expression: B cell
RGD
PMID:27980783
RGD:30310233
NCBI chr 6:122,530,768...122,541,139
Ensembl chr 6:122,530,760...122,541,139
G
Ank1
ankyrin 1, erythroid
IAGP
OMIM:609148 | OMIM:611162
MouseDO
NCBI chr 8:23,464,852...23,640,517
Ensembl chr 8:23,464,860...23,640,513
G
Apoe
apolipoprotein E
ISO
DNA:missense mutations:cds:p.C112R, p.C158R (human)
RGD
PMID:24116184
RGD:11039486
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
Aqp4
aquaporin 4
IAGP
OMIM:609148 | OMIM:611162
MouseDO
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
G
Cbs
cystathionine beta-synthase
susceptibility
ISO
DNA:insertion:cds: (844ins68) (human)
RGD
PMID:27198213
RGD:40903062
NCBI chr17:31,831,602...31,856,170
Ensembl chr17:31,827,868...31,856,212
G
Cd163
CD163 antigen
exacerbates severity
ISO
protein:increased expression:blood plasma (human) protein:altered expression:blood plasma (human)
RGD
PMID:22290142 PMID:18632918
RGD:127285797 , RGD:149735529
NCBI chr 6:124,281,596...124,307,488
Ensembl chr 6:124,281,615...124,307,486
G
Cd1d1
CD1d1 antigen
ameliorates exacerbates
IMP
RGD
PMID:12938235 PMID:24703850
RGD:127345117 , RGD:127345121
NCBI chr 3:86,903,141...86,919,665
Ensembl chr 3:86,903,141...86,906,748
G
Cd36
CD36 molecule
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Malaria, cerebral, susceptibility to | ClinVar Annotator: match by term: Malaria, susceptibility to
CTD OMIM ClinVar
PMID:10890433 PMID:18305138 PMID:19403559 PMID:25741868 PMID:28960434 PMID:33116287 More...
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
G
Cd40
CD40 antigen
severity
IMP
RGD
PMID:11485931
RGD:11352239
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cd40lg
CD40 ligand
severity
IMP
RGD
PMID:11485931
RGD:11352239
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
G
Cish
cytokine inducible SH2-containing protein
susceptibility
ISO
ClinVar Annotator: match by term: Malaria, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD OMIM
PMID:20484391
NCBI chr 9:107,173,858...107,179,983
Ensembl chr 9:107,173,225...107,179,983
G
Crp
C-reactive protein, pentraxin-related
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8730300
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
treatment disease_progression
IMP ISO
RGD
PMID:28892065 PMID:28892065
RGD:38455986 , RGD:38455986
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Ephb2
Eph receptor B2
IEP
mRNA:increased expression:liver
RGD
PMID:25784101
RGD:127285023
NCBI chr 4:136,374,850...136,563,637
Ensembl chr 4:136,374,850...136,563,299
G
Ephb3
Eph receptor B3
ISO
RGD
PMID:25784101
RGD:127285023
NCBI chr16:21,023,530...21,042,054
Ensembl chr16:21,023,505...21,042,055
G
Ephb6
Eph receptor B6
IEP
RGD
PMID:25784101
RGD:127285023
NCBI chr 6:41,581,940...41,597,445
Ensembl chr 6:41,582,416...41,597,443
G
Fcgr2b
Fc receptor, IgG, low affinity IIb
IAGP ISO
OMIM:609148 | OMIM:611162 CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Malaria, resistance to
MouseDO OMIM CTD ClinVar
PMID:12115230 PMID:15459183 PMID:16115811 PMID:16170323 PMID:17435165 PMID:20385827 More...
NCBI chr 1:170,786,186...170,804,141
Ensembl chr 1:170,786,186...170,804,116
G
Fcgr3
Fc receptor, IgG, low affinity III
ISO
DNA:missense mutation:cds:p.H131R (human)
RGD
PMID:19965803
RGD:5147921
NCBI chr 1:170,878,738...170,893,477
Ensembl chr 1:170,878,743...170,892,504
G
Foxp3
forkhead box P3
disease_progression
ISO
RGD
PMID:19338000 PMID:16169501
RGD:38455985 , RGD:38455992
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
susceptibility severity
ISO
DNA:SNPs: :multiple ClinVar Annotator: match by term: Malaria, susceptibility to CTD Direct Evidence: marker/mechanism DNA:point mutation:cds:c.968T>C (human)
ClinVar CTD OMIM RGD
PMID:5448 PMID:16832 PMID:511159 PMID:736032 PMID:853376 PMID:1303173 PMID:1303182 PMID:1459579 PMID:1551674 PMID:1562739 PMID:1611091 PMID:1631957 PMID:1805484 PMID:1879833 PMID:1924316 PMID:1945893 PMID:1953767 PMID:1972698 PMID:1978554 PMID:1978555 PMID:2253938 PMID:2255919 PMID:2263506 PMID:2307454 PMID:2321910 PMID:2393028 PMID:2503817 PMID:2572288 PMID:2602358 PMID:2606066 PMID:2633878 PMID:2836867 PMID:2849540 PMID:2912069 PMID:3198117 PMID:3201886 PMID:3338798 PMID:3393536 PMID:3446582 PMID:3591235 PMID:4283789 PMID:4359638 PMID:4379606 PMID:4388132 PMID:4392654 PMID:4435794 PMID:4721339 PMID:4837298 PMID:4974311 PMID:5081671 PMID:5305539 PMID:5316621 PMID:5369703 PMID:5485383 PMID:5641629 PMID:5673160 PMID:5770172 PMID:5775246 PMID:5844610 PMID:6015571 PMID:6698555 PMID:6714978 PMID:6714986 PMID:6805883 PMID:7203486 PMID:7211845 PMID:7327562 PMID:7390473 PMID:7440223 PMID:7577654 PMID:7590755 PMID:7789945 PMID:7803800 PMID:7806085 PMID:7825590 PMID:7858267 PMID:7947239 PMID:7947250 PMID:7949118 PMID:7959686 PMID:8118045 PMID:8193373 PMID:8244337 PMID:8364584 PMID:8370579 PMID:8447319 PMID:8471773 PMID:8490627 PMID:8533762 PMID:8537082 PMID:8611726 PMID:8807321 PMID:8807322 PMID:8860013 PMID:8956035 PMID:9017974 PMID:9192788 PMID:9233561 PMID:9250351 PMID:9299858 PMID:9332310 PMID:9342374 PMID:9444913 PMID:9589612 PMID:9674740 PMID:9858856 PMID:10192449 PMID:10221015 PMID:10502785 PMID:10571945 PMID:10643148 PMID:10734064 PMID:10782016 PMID:10916676 PMID:11024211 PMID:11042039 PMID:11146567 PMID:11243133 PMID:11295127 PMID:11400791 PMID:11445808 PMID:11499668 PMID:11601226 PMID:11793482 PMID:11852882 PMID:12028056 PMID:12064920 PMID:12105841 PMID:12187030 PMID:12215013 PMID:12367584 PMID:12497642 PMID:12737938 PMID:12768444 PMID:14014720 PMID:14278484 PMID:14505231 PMID:15223006 PMID:15315792 PMID:15349799 PMID:15502081 PMID:15625830 PMID:15727905 PMID:15766741 PMID:15906717 PMID:15996881 PMID:16088936 PMID:16119988 PMID:16136268 PMID:16143877 PMID:16155737 PMID:16193512 PMID:16329560 PMID:16356170 PMID:16461316 PMID:16513531 PMID:16528451 PMID:16607506 PMID:16777444 PMID:16927025 PMID:17018380 PMID:17233850 PMID:17524386 PMID:17587269 PMID:17726510 PMID:17959407 PMID:18043863 PMID:18046504 PMID:18177777 PMID:18226470 PMID:18270558 PMID:18329300 PMID:18452027 PMID:18568599 PMID:18677765 PMID:19422023 PMID:19589177 PMID:19594365 PMID:19632868 PMID:20007901 PMID:20200584 PMID:20203002 PMID:20236109 PMID:20582980 PMID:20602793 PMID:20621077 PMID:21153663 PMID:21302115 PMID:21441392 PMID:21446359 PMID:21479984 PMID:21507207 PMID:21637675 PMID:21677401 PMID:21874587 PMID:21931771 PMID:21989994 PMID:22018328 PMID:22139979 PMID:22164279 PMID:22165289 PMID:22171972 PMID:22237549 PMID:22293322 PMID:22307442 PMID:22452742 PMID:22552160 PMID:22770933 PMID:22906047 PMID:22906837 PMID:22963789 PMID:22963798 PMID:23006493 PMID:23057857 PMID:23144702 PMID:23365477 PMID:23479361 PMID:23926329 PMID:23965028 PMID:24033266 PMID:24117340 PMID:24134566 PMID:24460025 PMID:24505519 PMID:24551785 PMID:24586352 PMID:25071003 PMID:25141282 PMID:25201310 PMID:25326637 PMID:25440321 PMID:25536053 PMID:25541721 PMID:25548459 PMID:25741868 PMID:25775246 PMID:26060661 PMID:26226515 PMID:26633385 PMID:26823837 PMID:26829728 PMID:26990548 PMID:27040960 PMID:27053284 PMID:27213370 PMID:27287612 PMID:27495838 PMID:27519946 PMID:27535533 PMID:27853304 PMID:27880809 PMID:27884173 PMID:27980749 PMID:28028996 PMID:28195434 PMID:28492532 PMID:28512736 PMID:28583873 PMID:28756180 PMID:28852037 PMID:29072585 PMID:29141760 PMID:29248304 PMID:29300386 PMID:29333274 PMID:29339739 PMID:30045279 PMID:30077011 PMID:30096395 PMID:30097005 PMID:30161219 PMID:30314477 PMID:30315739 PMID:30674319 PMID:31294066 PMID:31489982 PMID:31525211 PMID:31609781 PMID:31833391 PMID:31862010 PMID:31863082 PMID:32180910 PMID:32387609 PMID:32425388 PMID:32641076 PMID:32702756 PMID:32860008 PMID:33051526 PMID:33069889 PMID:33072997 PMID:33128437 PMID:33413378 PMID:33628497 PMID:33636823 PMID:34134107 PMID:34620237 PMID:34659341 PMID:34762759 PMID:34895177 PMID:34934109 PMID:34966093 PMID:35313968 PMID:35753512 PMID:35840819 PMID:36150187 PMID:36212142 PMID:36315991 PMID:36353116 PMID:36703223 PMID:36949502 PMID:38592584 PMID:38645242 PMID:25015414 PMID:24615128 More...
RGD:10449111 , RGD:10449115
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gypa
glycophorin A
ISO
CTD Direct Evidence: marker/mechanism
OMIM CTD
NCBI chr 8:81,220,674...81,237,414
Ensembl chr 8:81,220,410...81,237,171
G
Gypc
glycophorin C
ISO
ClinVar Annotator: match by term: Malaria, resistance to CTD Direct Evidence: marker/mechanism
ClinVar CTD OMIM
PMID:1991173 PMID:5011657 PMID:8157284 PMID:11719395 PMID:12469115 PMID:21061946 More...
NCBI chr18:32,661,373...32,693,087
Ensembl chr18:32,661,375...32,693,087
G
Hbb-b1
hemoglobin, beta adult major chain
resistance
ISO
Hemoglobin C; DNA:polymorphism:CDS:69G>A, amino acid E6K ClinVar Annotator: match by term: Malaria, resistance to | ClinVar Annotator: match by term: Malaria, susceptibility to CTD Direct Evidence: marker/mechanism
RGD ClinVar CTD OMIM
PMID:14973 PMID:81926 PMID:88735 PMID:893136 PMID:909565 PMID:1112610 PMID:1301203 PMID:1353069 PMID:1376298 PMID:1390250 PMID:1427786 PMID:1428944 PMID:1463768 PMID:1483699 PMID:1610915 PMID:1634236 PMID:1634368 PMID:1680789 PMID:1709134 PMID:1732017 PMID:1734721 PMID:1769663 PMID:1802884 PMID:1873227 PMID:1917531 PMID:1960615 PMID:1967205 PMID:1986365 PMID:1986379 PMID:2001456 PMID:2004023 PMID:2030155 PMID:2064964 PMID:2123063 PMID:2197725 PMID:2200760 PMID:2200762 PMID:2239966 PMID:2291577 PMID:2296310 PMID:2298457 PMID:2346726 PMID:2393712 PMID:2412200 PMID:2430648 PMID:2446680 PMID:2458145 PMID:2467892 PMID:2577233 PMID:2579336 PMID:2582106 PMID:2599884 PMID:2606476 PMID:2606727 PMID:2634667 PMID:2713503 PMID:2753736 PMID:2867271 PMID:2888754 PMID:2891298 PMID:2893541 PMID:2898142 PMID:2898460 PMID:2898955 PMID:2903765 PMID:2920213 PMID:2987224 PMID:2987809 PMID:3031297 PMID:3048433 PMID:3114175 PMID:3170235 PMID:3267215 PMID:3354556 PMID:3422218 PMID:3462712 PMID:3623977 PMID:3683554 PMID:3690667 PMID:3691763 PMID:3752087 PMID:3821796 PMID:3828533 PMID:3840039 PMID:3859465 PMID:3942130 PMID:3955238 PMID:3957690 PMID:4232783 PMID:4351905 PMID:4683875 PMID:5481775 PMID:5609824 PMID:5619995 PMID:5658717 PMID:5863839 PMID:5915974 PMID:6019668 PMID:6061750 PMID:6162860 PMID:6166632 PMID:6188062 PMID:6189507 PMID:6190800 PMID:6198908 PMID:6246994 PMID:6264391 PMID:6264477 PMID:6268660 PMID:6270663 PMID:6272289 PMID:6275383 PMID:6280057 PMID:6285354 PMID:6292840 PMID:6304979 PMID:6308558 PMID:6310991 PMID:6316272 PMID:6320218 PMID:6434492 PMID:6457059 PMID:6469698 PMID:6572978 PMID:6583683 PMID:6583702 PMID:6584911 PMID:6585831 PMID:6668188 PMID:6695908 PMID:6714226 PMID:6733281 PMID:6745619 PMID:6821648 PMID:6826539 PMID:6896219 PMID:6985481 PMID:7076659 PMID:7104238 PMID:7137165 PMID:7151176 PMID:7173395 PMID:7177196 PMID:7229029 PMID:7312624 PMID:7384810 PMID:7395858 PMID:7522523 PMID:7558878 PMID:7668219 PMID:7683931 PMID:7795641 PMID:7852087 PMID:7908281 PMID:7909640 PMID:7993409 PMID:8095930 PMID:8172199 PMID:8199027 PMID:8199597 PMID:8201467 PMID:8262525 PMID:8330981 PMID:8373896 PMID:8435318 PMID:8454469 PMID:8462981 PMID:8477263 PMID:8518184 PMID:8602996 PMID:8619407 PMID:8718703 PMID:8839873 PMID:8917506 PMID:8980256 PMID:9028827 PMID:9048934 PMID:9101288 PMID:9113933 PMID:9140720 PMID:9163586 PMID:9223924 PMID:9225979 PMID:9340427 PMID:9342003 PMID:9401495 PMID:9450794 PMID:9490703 PMID:9495372 PMID:9536098 PMID:9556665 PMID:9586437 PMID:9653159 PMID:9834244 PMID:9845707 PMID:9859938 PMID:9949622 PMID:10203101 PMID:10335989 PMID:10583251 PMID:10606872 PMID:10612821 PMID:10815781 PMID:11001883 PMID:11179419 PMID:11186258 PMID:11300348 PMID:11425418 PMID:11501714 PMID:11559932 PMID:11713529 PMID:11741197 PMID:11791873 PMID:11830454 PMID:11857746 PMID:11880644 PMID:11939508 PMID:11939510 PMID:12000828 PMID:12124399 PMID:12144057 PMID:12149194 PMID:12368169 PMID:12383672 PMID:12403498 PMID:12702481 PMID:12764548 PMID:12779277 PMID:12818227 PMID:12850492 PMID:13066514 PMID:13108995 PMID:13115700 PMID:13369537 PMID:13464827 PMID:13618691 PMID:13685866 PMID:13716853 PMID:13852872 PMID:14084634 PMID:14091853 PMID:14405428 PMID:14492555 PMID:14555304 PMID:14576320 PMID:14613965 PMID:14734204 PMID:14808148 PMID:15000665 PMID:15108284 PMID:15114532 PMID:15181845 PMID:15278762 PMID:15395398 PMID:15470211 PMID:15481886 PMID:15543018 PMID:15654898 PMID:15658184 PMID:15973412 PMID:16001361 PMID:16044458 PMID:16103715 PMID:16114182 PMID:16175509 PMID:16199547 PMID:16291734 PMID:16311287 PMID:16421096 PMID:16470532 PMID:16750922 PMID:16821247 PMID:17145605 PMID:17278112 PMID:17287491 PMID:17331080 PMID:17365006 PMID:17486505 PMID:17576681 PMID:17654071 PMID:17774955 PMID:17932132 PMID:17949282 PMID:17994378 PMID:18024613 PMID:18048408 PMID:18096416 PMID:18192399 PMID:18294253 PMID:18568278 PMID:18603555 PMID:18818920 PMID:18954999 PMID:18976160 PMID:19000664 PMID:19061217 PMID:19092326 PMID:19254853 PMID:19429541 PMID:19465909 PMID:19486366 PMID:19657836 PMID:19657842 PMID:19727720 PMID:19758965 PMID:19841268 PMID:19960060 PMID:20132300 PMID:20181291 PMID:20236848 PMID:20301551 PMID:20301599 PMID:20305663 PMID:20353354 PMID:20395516 PMID:20412082 PMID:20437613 PMID:20628988 PMID:20642336 PMID:20704537 PMID:20737602 PMID:20788973 PMID:20861612 PMID:20954261 PMID:20981092 PMID:21045822 PMID:21119755 PMID:21131035 PMID:21194254 PMID:21228398 PMID:21250876 PMID:21302591 PMID:21329186 PMID:21389146 PMID:21417574 PMID:21509314 PMID:21529713 PMID:21732929 PMID:21797703 PMID:22010933 PMID:22028795 PMID:22075726 PMID:22110956 PMID:22188014 PMID:22200002 PMID:22239493 PMID:22244832 PMID:22260787 PMID:22271886 PMID:22335963 PMID:22392582 PMID:22471768 PMID:22494447 PMID:22563936 PMID:22625666 PMID:22851993 PMID:22957039 PMID:22975760 PMID:23065522 PMID:23144702 PMID:23162295 PMID:23234478 PMID:23297836 PMID:23321370 PMID:23348723 PMID:23425204 PMID:23457306 PMID:23590658 PMID:23591685 PMID:23637309 PMID:23859443 PMID:24052702 PMID:24055728 PMID:24099628 PMID:24106605 PMID:24123366 PMID:24200214 PMID:24245819 PMID:24368026 PMID:24369358 PMID:24493127 PMID:24581976 PMID:24616059 PMID:24616209 PMID:24754789 PMID:24777453 PMID:24857915 PMID:24880717 PMID:25000193 PMID:25016698 PMID:25023084 PMID:25023085 PMID:25087612 PMID:25089872 PMID:25113778 PMID:25130136 PMID:25135424 PMID:25155404 PMID:25332589 PMID:25370867 PMID:25405919 PMID:25408857 PMID:25412720 PMID:25480500 PMID:25488433 PMID:25525159 PMID:25572186 PMID:25617386 PMID:25666204 PMID:25677748 PMID:25741868 PMID:25825561 PMID:25849334 PMID:25856402 PMID:25976460 PMID:26029792 PMID:26041415 PMID:26044735 PMID:26076395 PMID:26076396 PMID:26084319 PMID:26097845 PMID:26193974 PMID:26275168 PMID:26290351 PMID:26291967 PMID:26366554 PMID:26372199 PMID:26436569 PMID:26467025 PMID:26554253 PMID:26554862 PMID:26594346 PMID:26661037 PMID:26771086 PMID:26897028 PMID:26956563 PMID:27117572 PMID:27199182 PMID:27207683 PMID:27251090 PMID:27254408 PMID:27263053 PMID:27427187 PMID:27453201 PMID:27690257 PMID:27756326 PMID:27821015 PMID:27823958 PMID:27828729 PMID:27829304 PMID:27884173 PMID:27979672 PMID:28251416 PMID:28276871 PMID:28356267 PMID:28361595 PMID:28366028 PMID:28385923 PMID:28391758 PMID:28492532 PMID:28635337 PMID:28667000 PMID:28670940 PMID:28802248 PMID:28865746 PMID:29295702 PMID:29319890 PMID:29484903 PMID:29695942 PMID:30002798 PMID:30033078 PMID:30046479 PMID:30249157 PMID:30315176 PMID:30489691 PMID:30604644 PMID:30820323 PMID:30843739 PMID:31096791 PMID:31130284 PMID:31134759 PMID:31190580 PMID:31268351 PMID:31411089 PMID:31456457 PMID:31553106 PMID:31589614 PMID:31714438 PMID:31718331 PMID:31890591 PMID:32039214 PMID:32069775 PMID:32126744 PMID:32190157 PMID:32412692 PMID:32472543 PMID:32527859 PMID:32581362 PMID:32664780 PMID:32860008 PMID:32869674 PMID:33000750 PMID:33091040 PMID:33116287 PMID:33335418 PMID:33491330 PMID:33602051 PMID:33829933 PMID:33851260 PMID:34092029 PMID:34334128 PMID:34426522 PMID:34749363 PMID:35023007 PMID:35052472 PMID:35982159 PMID:35982160 PMID:36073655 PMID:37826942 More...
RGD:1600894
G
Hbb-b2
hemoglobin, beta adult minor chain
resistance
ISO
RGD
PMID:11001883
RGD:1600894
G
Hmox1
heme oxygenase 1
IAGP
OMIM:609148 | OMIM:611162
MouseDO
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hp
haptoglobin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8730300 PMID:16597321
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Icam1
intercellular adhesion molecule 1
susceptibility
IAGP ISO
OMIM:609148 | OMIM:611162 ClinVar Annotator: match by term: Malaria, cerebral, susceptibility to | ClinVar Annotator: match by term: Malaria, susceptibility to CTD Direct Evidence: marker/mechanism
MouseDO ClinVar CTD OMIM
PMID:9259284 PMID:9861406 PMID:10417733 PMID:10699175 PMID:23609612 PMID:25741868 More...
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ifng
interferon gamma
IAGP
OMIM:609148 | OMIM:611162
MouseDO
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Ikbkg
inhibitor of kappaB kinase gamma
ISO
ClinVar Annotator: match by term: Malaria, susceptibility to
ClinVar
PMID:1945893 PMID:3198117 PMID:6805883 PMID:7803800 PMID:8244337 PMID:8471773 PMID:9589612 PMID:10502785 PMID:11601226 PMID:12064920 PMID:15727905 PMID:16329560 PMID:16607506 PMID:25741868 PMID:28492532 PMID:29300386 PMID:29339739 PMID:30045279 PMID:30315739 PMID:31489982 PMID:31863082 PMID:33051526 PMID:33072997 PMID:34659341 PMID:34762759 PMID:34895177 PMID:35313968 PMID:35840819 PMID:36353116 PMID:38592584 More...
NCBI chr X:73,436,883...73,498,013
Ensembl chr X:73,436,896...73,497,460
G
Il1rl1
interleukin 1 receptor-like 1
IMP
RGD
PMID:28359899
RGD:39938859
NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575
G
Il21
interleukin 21
exacerbates
IMP
RGD
PMID:25763578
RGD:127285358
NCBI chr 3:37,276,908...37,286,785
Ensembl chr 3:37,276,908...37,286,785
G
Il27
interleukin 27
ameliorates
IMP
RGD
PMID:24522137 PMID:26968425
RGD:126790512 , RGD:11530371
NCBI chr 7:126,188,181...126,194,197
Ensembl chr 7:126,188,182...126,194,113
G
Il33
interleukin 33
IEP
protein:increased expression:serum:
RGD
PMID:28359899
RGD:39938859
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
Kir3dl1
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
severity
ISO
DNA:deletion:cds
RGD
PMID:21889618
RGD:38676475
NCBI chr X:135,418,748...135,435,055
Ensembl chr X:135,418,748...135,435,058
G
LOC111365144
Nos2 promoter region
ISO
ClinVar Annotator: match by term: Malaria, resistance to
ClinVar
PMID:12433515
NCBI chr11:78,810,061...78,811,815
G
Ltbr
lymphotoxin B receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15788153
NCBI chr 6:125,283,534...125,291,026
Ensembl chr 6:125,283,534...125,290,848
G
Mapkapk3
mitogen-activated protein kinase-activated protein kinase 3
ISO
ClinVar Annotator: match by term: Malaria, susceptibility to
ClinVar
PMID:20484391
NCBI chr 9:107,132,125...107,167,082
Ensembl chr 9:107,132,126...107,167,076
G
Mir122
microRNA 122
treatment
IEP
RGD
PMID:28123381
RGD:35673288
NCBI chr18:65,381,932...65,381,997
Ensembl chr18:65,381,932...65,381,997
G
Mir142
microRNA 142
treatment
IEP
RGD
PMID:28123381
RGD:35673288
NCBI chr11:87,647,690...87,647,753
Ensembl chr11:87,647,690...87,647,753
G
Mir669n
microRNA 669n
treatment
IEP
RGD
PMID:28123381
RGD:35673288
NCBI chr 3:115,773,551...115,773,604
Ensembl chr 3:115,773,551...115,773,604
G
Mir709
microRNA 709
treatment
IEP
RGD
PMID:28123381
RGD:35673288
NCBI chr 8:84,812,728...84,812,815
Ensembl chr 8:84,812,728...84,812,815
G
Mirlet7a-1
microRNA let7a-1
treatment
IEP
RGD
PMID:28123381
RGD:35673288
NCBI chr13:48,691,655...48,691,748
Ensembl chr13:48,691,655...48,691,748
G
Mirlet7c-1
microRNA let7c-1
treatment
IEP
RGD
PMID:28123381
RGD:35673288
NCBI chr16:77,396,545...77,396,638
Ensembl chr16:77,396,545...77,396,638
G
Mki67
antigen identified by monoclonal antibody Ki 67
IDA
associated with Lung Neoplasms
RGD
PMID:21931708
RGD:6483517
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
G
Ncr3-ps
natural cytotoxicity triggering receptor 3, pseudogene
susceptibility
ISO
ClinVar Annotator: match by term: Malaria, severe, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD OMIM
PMID:17208487
NCBI chr17:35,399,512...35,403,785
Ensembl chr17:35,399,511...35,403,638
G
Nos2
nitric oxide synthase 2, inducible
ISO
ClinVar Annotator: match by term: Malaria, resistance to | ClinVar Annotator: match by term: Malaria, severe, resistance to | ClinVar Annotator: match by term: Malaria, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar CTD OMIM
PMID:9457101 PMID:12433515 PMID:31995689
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Pklr
pyruvate kinase liver and red blood cell
susceptibility
ISO IAGP
DNA:mutations, haplotype:multiple (human) OMIM:609148 | OMIM:611162 DNA:missense mutation:cds:p.I90N (mouse)
MouseDO RGD
PMID:20377593 PMID:14595440
RGD:11535999 , RGD:11537407
NCBI chr 3:89,043,429...89,054,122
Ensembl chr 3:89,043,449...89,054,091
G
Prf1
perforin 1 (pore forming protein)
IMP
RGD
PMID:21525386
RGD:6482803
NCBI chr10:61,133,530...61,140,463
Ensembl chr10:61,133,612...61,140,459
G
Procr
protein C receptor, endothelial
disease_progression
ISO
RGD
PMID:27671831
RGD:126848795
NCBI chr 2:155,592,159...155,597,391
Ensembl chr 2:155,593,037...155,597,391
G
Slc19a1
solute carrier family 19 (folate transporter), member 1
ISO
DNA:SNP::g.80G>A (human)
RGD
PMID:27198213
RGD:40903062
NCBI chr10:76,868,103...76,886,266
Ensembl chr10:76,868,075...76,896,836
G
Slc4a1
solute carrier family 4 (anion exchanger), member 1
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Malaria, cerebral, resistance to | ClinVar Annotator: match by term: Malaria, susceptibility to
CTD ClinVar
PMID:1378323 PMID:1722314 PMID:1737855 PMID:2146504 PMID:6338046 PMID:7689982 PMID:7919393 PMID:7949112 PMID:8434259 PMID:8704215 PMID:8943874 PMID:9207478 PMID:9312167 PMID:9600966 PMID:9854053 PMID:10403343 PMID:10926824 PMID:10942416 PMID:12087557 PMID:12750988 PMID:12938018 PMID:14618420 PMID:16107207 PMID:16420521 PMID:17215882 PMID:18266205 PMID:19229254 PMID:19289107 PMID:19625994 PMID:20068363 PMID:20151848 PMID:20421175 PMID:20799361 PMID:22126643 PMID:22518001 PMID:22609520 PMID:23255290 PMID:24652967 PMID:25741868 PMID:28045035 PMID:28188436 PMID:28233610 PMID:28492532 PMID:28542241 PMID:29627839 PMID:30192042 PMID:30230413 PMID:31147440 PMID:31672324 PMID:31959358 PMID:32071839 PMID:33532864 PMID:34746046 PMID:35738466 More...
NCBI chr11:102,239,646...102,256,107
Ensembl chr11:102,239,650...102,257,029
G
Spp1
secreted phosphoprotein 1
IDA
RGD
PMID:16552072
RGD:1581333
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
G
Tbx21
T-box 21
ISO
RGD
PMID:19338000
RGD:38455985
NCBI chr11:96,988,833...97,006,157
Ensembl chr11:96,988,897...97,006,157
G
Tirap
toll-interleukin 1 receptor (TIR) domain-containing adaptor protein
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Malaria, resistance to
CTD OMIM ClinVar
PMID:16991088 PMID:17322885 PMID:18305471 PMID:25741868
NCBI chr 9:35,095,687...35,111,587
Ensembl chr 9:35,095,847...35,111,587
G
Tnf
tumor necrosis factor
susceptibility
ISO
DNA:polymorphism:promoter:-376G>A ClinVar Annotator: match by term: Malaria, cerebral, susceptibility to CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:8056188 PMID:9818939 PMID:10369255 PMID:10450718 PMID:11261930 PMID:11506397 PMID:11826025 PMID:11896460 PMID:12485196 PMID:12746914 PMID:12759288 PMID:14681301 PMID:14718719 PMID:16418737 PMID:16720636 PMID:16865291 PMID:16909270 PMID:18050183 PMID:18713756 PMID:19365401 PMID:22760475 PMID:22992668 PMID:10369255 More...
RGD:1624967
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Trem1
triggering receptor expressed on myeloid cells 1
severity
ISO
DNA:SNP: :rs2234237A>T (human)
RGD
PMID:27671831
RGD:126848795
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
Tslp
thymic stromal lymphopoietin
IEP
mRNA:altered expression:multiple (mouse)
RGD
PMID:28955823
RGD:38596344
NCBI chr18:32,948,436...32,952,852
Ensembl chr18:32,948,436...32,952,850
G
Fcgr4
Fc receptor, IgG, low affinity IV
severity susceptibility
ISO
DNA:polymorphism: :p.F176V (human)
RGD
PMID:20231419 PMID:23045477
RGD:11040771 , RGD:11344971
NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330
G
Slc4a1
solute carrier family 4 (anion exchanger), member 1
severity
ISO
DNA:snp:promoter:g.-5699T>C (human)
RGD
PMID:16960783
RGD:10450507
NCBI chr11:102,239,646...102,256,107
Ensembl chr11:102,239,650...102,257,029
G
Tlr9
toll-like receptor 9
susceptibility
ISO
DNA:SNP:promoter:g.-1237T>C (rs5743836) (human)
RGD
PMID:23045477
RGD:11344971
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
G
Camp
cathelicidin antimicrobial peptide
ameliorates
ISO
RGD
PMID:15645239
RGD:458925287
NCBI chr 9:109,676,445...109,678,524
Ensembl chr 9:109,676,447...109,678,685
G
Crp
C-reactive protein, pentraxin-related
treatment
ISO
RGD
PMID:15645239
RGD:458925287
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Il27
interleukin 27
IEP ISO
protein:increased expression:blood serum (mouse) protien:increased expression:blood serum (human)
RGD
PMID:31818960 PMID:22766719
RGD:126790524 , RGD:126790543
NCBI chr 7:126,188,181...126,194,197
Ensembl chr 7:126,188,182...126,194,113
G
Pla2g2a
phospholipase A2, group IIA (platelets, synovial fluid)
susceptibility
ISO
DNA:SNP:enhancer: (rs1891320) (human)
RGD
PMID:20463618
RGD:6482720
NCBI chr 4:138,559,168...138,562,500
Ensembl chr 4:138,559,171...138,562,497
G
Abo
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
susceptibility
ISO
DNA:SNPs,haplotype:multiple
RGD
PMID:18003641
RGD:39938831
NCBI chr 2:26,732,508...26,754,973
Ensembl chr 2:26,732,515...26,754,991
G
Adamts13
ADAM metallopeptidase with thrombospondin type 1 motif 13
ISO
protein:decreased activity:plasma (human)
RGD
PMID:20062916
RGD:10449041
NCBI chr 2:26,863,363...26,899,638
Ensembl chr 2:26,863,428...26,899,640
G
Bsg
basigin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22080952 PMID:26195724
NCBI chr10:79,540,192...79,547,813
Ensembl chr10:79,540,325...79,547,803
G
Cast
calpastatin
ISO
protein:alter localization:erythrocyte
RGD
PMID:17359359
RGD:5509812
NCBI chr13:74,840,485...74,956,993
Ensembl chr13:74,840,487...74,956,929
G
Ccl4
C-C motif chemokine ligand 4
ISO
mRNA, protein:increased expression:blood,
RGD
PMID:15972509
RGD:5683898
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
G
Clec11a
C-type lectin domain family 11, member a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19884328
NCBI chr 7:43,953,190...43,956,383
Ensembl chr 7:43,952,111...43,956,326
G
Cyp2c38
cytochrome P450, family 2, subfamily c, polypeptide 38
treatment
ISO
DNA:polymorphisms::
RGD
PMID:10471063
RGD:124713538
NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
G
Fas
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625619
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fcgr3
Fc receptor, IgG, low affinity III
severity
ISO
DNA:missense mutation:cds:p.R131H (rs1801274) (human)
RGD
PMID:18194515
RGD:5147927
NCBI chr 1:170,878,738...170,893,477
Ensembl chr 1:170,878,743...170,892,504
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
severity
ISO
DNA:missense mutation:cds:202G>A (p.V68M) (human)
RGD
PMID:24943486
RGD:10449113
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gstp1
glutathione S-transferase, pi 1
severity
ISO
RGD
PMID:19635899
RGD:10450848
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
susceptibility
ISO
DNA:polymorphism:cds:HLA-DQB1*0501 (human)
RGD
PMID:11076705
RGD:11041780
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
Hbb-b1
hemoglobin, beta adult major chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20305663
G
Hp
haptoglobin
severity
ISO
DNA:missense mutation:cds:p.K54E (human)
RGD
PMID:24478401
RGD:11041793
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Il13
interleukin 13
ISO
protein:increased expression:plasma
RGD
PMID:21985368
RGD:5684362
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Mbl2
mannose-binding lectin (protein C) 2
susceptibility
ISO
DNA:haplotype:exon:
RGD
PMID:18396436
RGD:11530064
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
G
Tnf
tumor necrosis factor
severity
ISO
protein:increased expression:plasma
RGD
PMID:1984482
RGD:10450571
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Ackr1
atypical chemokine receptor 1 (Duffy blood group)
ISO
ClinVar Annotator: match by term: Resistance to Plasmodium vivax infection
OMIM ClinVar
PMID:7663520 PMID:8547665 PMID:8651934 PMID:10570183 PMID:10791881 PMID:17304246 PMID:18179887 PMID:18621010 PMID:19180233 PMID:19620399 PMID:20932074 More...
NCBI chr 1:173,159,457...173,161,079
Ensembl chr 1:173,159,453...173,161,317
G
Il10
interleukin 10
ISO
RGD
PMID:24717969
RGD:11041890
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Mir146
microRNA 146
susceptibility
ISO
miRNA:SNP: (rs2910164) (human)
RGD
PMID:30642347
RGD:126925184
NCBI chr11:43,265,224...43,265,288
Ensembl chr11:43,265,224...43,265,288
G
A2m
alpha-2-macroglobulin
treatment
ISO
RGD
PMID:2424486
RGD:10046036
NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186
G
Ace
angiotensin I converting enzyme
severity
ISO
DNA:SNP, insertion/deletion:promoter, intron: (rs4291, rs4646994)
RGD
PMID:28336767
RGD:39939121
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Adk
adenosine kinase
IMP
RGD
PMID:8207212
RGD:6482670
NCBI chr14:21,102,622...21,498,637
Ensembl chr14:21,102,642...21,498,637
G
Adm
adrenomedullin
ISO
RGD
PMID:17318497 PMID:17766482
RGD:1625310 , RGD:1642599
NCBI chr 7:110,226,864...110,229,027
Ensembl chr 7:110,226,868...110,229,027
G
Adrb2
adrenergic receptor, beta 2
disease_progression treatment
ISO
DNA:polymorphism: :rs1042717(human)
RGD
PMID:19850944 PMID:16076286
RGD:8548487 , RGD:8548529
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
G
Ager
advanced glycosylation end product-specific receptor
IAGP
RGD
PMID:21270403
RGD:6767566
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Aqp1
aquaporin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24028651
NCBI chr 6:55,313,284...55,325,540
Ensembl chr 6:55,313,417...55,325,540
G
C5ar1
complement component 5a receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18063050
NCBI chr 7:15,980,668...15,993,465
Ensembl chr 7:15,980,668...15,993,465
G
Cckbr
cholecystokinin B receptor
ISO
mRNA:increased expression:myocardium
RGD
PMID:15948246
RGD:2311332
NCBI chr 7:105,075,201...105,085,546
Ensembl chr 7:105,074,938...105,120,105
G
Ccl2
C-C motif chemokine ligand 2
disease_progression
ISO
RGD
PMID:28834779
RGD:14995949
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Cd274
CD274 antigen
severity
ISO
protein:increased expression:serum protein:increased expression:lymphocyte, mononcyte
RGD
PMID:29702526 PMID:26063974
RGD:40822808 , RGD:41410786
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
G
Elane
elastase, neutrophil expressed
treatment
ISO
RGD
PMID:18323746
RGD:10450579
NCBI chr10:79,722,146...79,724,050
Ensembl chr10:79,722,081...79,724,049
G
Eno2
enolase 2, gamma neuronal
ISO
proteiin:increased expression:serum
RGD
PMID:17083782
RGD:2293748
NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636
G
F2
coagulation factor II
severity
ISO
protein:decreased expression:blood plasma (human)
RGD
PMID:2788582
RGD:40822807
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
Fancc
Fanconi anemia, complementation group C
IMP
RGD
PMID:17404312
RGD:11045879
NCBI chr13:63,452,519...63,645,126
Ensembl chr13:63,432,857...63,645,092
G
Gc
vitamin D binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17852808
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
G
Grk2
G protein-coupled receptor kinase 2
ISO
mRNA:decreased expression:polymorphonuclear leukocyte
RGD
PMID:24465168
RGD:126848796
NCBI chr19:4,336,029...4,356,356
Ensembl chr19:4,336,029...4,356,250
G
H2-Ea
histocompatibility 2, class II antigen E alpha
disease_progression
ISO
associated with Burns CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28771573 PMID:17568330 PMID:15644645
RGD:5490160 , RGD:5490203
NCBI chr17:34,560,926...34,563,619
Ensembl chr17:34,560,926...34,563,618
G
H2-Eb1
histocompatibility 2, class II antigen E beta
ISO
mRNA:decreased expression:blood
RGD
PMID:15644645
RGD:5490203
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
G
Hmox1
heme oxygenase 1
ISO
RGD
PMID:18208666
RGD:4145362
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hspa1b
heat shock protein 1B
susceptibility
ISO
associated wit community-acquired pneumonia;DNA:SNP: :1267A>G (human)
RGD
PMID:12771604
RGD:5147601
NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
G
Ido1
indoleamine 2,3-dioxygenase 1
severity
ISO
protein:increased activity, increased expression:plasma, heart (human)
RGD
PMID:21765346
RGD:39939075
NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
G
Ifng
interferon gamma
ISO
protein:increased expression:plasma
RGD
PMID:25403265
RGD:38455982
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Il10
interleukin 10
onset severity
IAGP IEP ISO IMP
protein:increased expression:lung (mouse) protein:increased expression:plasma
RGD
PMID:12117955 PMID:28659355 PMID:25403265 PMID:7593621
RGD:1598471 , RGD:40890272 , RGD:38455982 , RGD:11049456
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il19
interleukin 19
IMP
RGD
PMID:18246602
RGD:5037232
NCBI chr 1:130,860,393...130,873,194
Ensembl chr 1:130,860,393...130,867,852
G
Il1b
interleukin 1 beta
severity
IEP
protein:increased expression:lung (mouse)
RGD
PMID:28659355
RGD:40890272
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
treatment susceptibility
ISO
human gene in a mouse model associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism::
RGD
PMID:15516267 PMID:23014359
RGD:8551736 , RGD:11522756
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il20ra
interleukin 20 receptor, alpha
IEP
mRNA:increased expression:multiple
RGD
PMID:18246602
RGD:5037232
NCBI chr10:19,587,421...19,635,801
Ensembl chr10:19,588,318...19,635,801
G
Il20rb
interleukin 20 receptor beta
IEP
mRNA:increased expression:multiple
RGD
PMID:18246602
RGD:5037232
NCBI chr 9:100,339,772...100,368,526
Ensembl chr 9:100,339,772...100,368,841
G
Il27
interleukin 27
IEP
protein, mRNA:increased expression:blood serum, spleen (mouse)
RGD
PMID:20435892
RGD:126790535
NCBI chr 7:126,188,181...126,194,197
Ensembl chr 7:126,188,182...126,194,113
G
Il6
interleukin 6
treatment
IMP
RGD
PMID:2124237
RGD:11060276
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Mbl2
mannose-binding lectin (protein C) 2
susceptibility
ISO
associated with acute pyelonephritis;DNA:SNPs, missense mutations, haplotypes:promoter, cds:multiple
RGD
PMID:17202308 PMID:17202308
RGD:6903268 , RGD:6903268
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
G
Mc2r
melanocortin 2 receptor
ISO
protein:increased expression:liver (rat)
RGD
PMID:2822467
RGD:6484558
NCBI chr18:68,539,970...68,562,391
Ensembl chr18:68,539,978...68,562,391
G
Mif
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
ISO
RGD
PMID:17381395 PMID:17565848
RGD:4891013 , RGD:1641978
NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
G
Mir155
microRNA 155
ISO
RGD
PMID:29979224
RGD:21081538
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mir21a
microRNA 21a
exacerbates ameliorates
IMP
RGD
PMID:28437377 PMID:31189875
RGD:41404641 , RGD:41404698
NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
G
Mir494
microRNA 494
severity
ISO
RGD
PMID:30783439
RGD:150527846
NCBI chr12:109,681,752...109,681,836
Ensembl chr12:109,681,752...109,681,836
G
mt-Nd1
NADH dehydrogenase 1, mitochondrial
susceptibility
ISO
associated with Burns; DNA:missense mutation:cds:m.4216T>C (human)
RGD
PMID:19487983
RGD:5148017
NCBI chr MT:2,751...3,707
Ensembl chr MT:2,751...3,707
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
treatment
ISO
RGD
PMID:11961112
RGD:126928137
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nos2
nitric oxide synthase 2, inducible
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8745224 PMID:16601845
RGD:1580268
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nppc
natriuretic peptide type C
ISO
protein:increased expression:plasma
RGD
PMID:8117275
RGD:1642297
NCBI chr 1:86,594,015...86,598,295
Ensembl chr 1:86,594,013...86,598,293
G
Ogg1
8-oxoguanine DNA-glycosylase 1
IMP
RGD
PMID:15677345
RGD:8657146
NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029
G
Parp1
poly (ADP-ribose) polymerase family, member 1
IMP
RGD
PMID:12445868
RGD:10414070
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pdcd1
programmed cell death 1
severity
ISO
protein:increased expression:serum protein:increased expression:lymphocyte, mononcyte
RGD
PMID:29702526 PMID:26063974
RGD:40822808 , RGD:41410786
NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
severity
IMP
RGD
PMID:28659355
RGD:40890272
NCBI chr 4:149,733,625...149,787,023
Ensembl chr 4:149,733,625...149,787,028
G
Plaur
plasminogen activator, urokinase receptor
IMP
RGD
PMID:20693875
RGD:6484122
NCBI chr 7:24,161,857...24,175,393
Ensembl chr 7:24,161,909...24,175,393
G
Proc
protein C
treatment
IMP ISO
RGD
PMID:19320827 PMID:21850534
RGD:11100015 , RGD:11100041
NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
G
Ptx3
pentraxin related gene
ISO
protein:increased expression:plasma (human)
RGD
PMID:30687307
RGD:38508896
NCBI chr 3:66,127,308...66,133,227
Ensembl chr 3:66,127,331...66,133,226
G
Ren1
renin 1 structural
exacerbates
ISO
protein:increased activity:blood plasma (human)
RGD
PMID:31723628
RGD:125097502
NCBI chr 1:133,278,412...133,288,058
Ensembl chr 1:133,278,248...133,288,063
G
Sell
selectin, lymphocyte
ISO
protein:increased expression:plasma
RGD
PMID:19375498
RGD:5685700
NCBI chr 1:163,889,556...163,908,354
Ensembl chr 1:163,889,551...163,911,750
G
Serpinc1
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1
treatment
ISO
RGD
PMID:16732381
RGD:1599323
NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
susceptibility
ISO
associated with Pneumonia; DNA:polymorphism:promoter:rs1799768 (human)
RGD
PMID:20429897
RGD:4144828
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Serpinf1
serine (or cysteine) peptidase inhibitor, clade F, member 1
severity
ISO
protein:decreased expression:plasma (human)
RGD
PMID:6158114
RGD:36174004
NCBI chr11:75,300,855...75,313,449
Ensembl chr11:75,300,595...75,313,527
G
Serping1
serine (or cysteine) peptidase inhibitor, clade G, member 1
treatment
ISO
RGD
PMID:8172580
RGD:8661646
NCBI chr 2:84,595,704...84,605,748
Ensembl chr 2:84,595,731...84,605,788
G
Sftpb
surfactant associated protein B
ISO
associated with Pneumonia;DNA:polymorphism: :1580C>T (human)
RGD
PMID:15190959
RGD:4143404
NCBI chr 6:72,281,594...72,291,354
Ensembl chr 6:72,281,594...72,291,354
G
Socs1
suppressor of cytokine signaling 1
severity
IMP
RGD
PMID:19469017
RGD:150573701
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
G
Tbxa2r
thromboxane A2 receptor
treatment
ISO
RGD
PMID:7816742
RGD:11059599
NCBI chr10:81,164,102...81,171,008
Ensembl chr10:81,164,565...81,171,006
G
Tfpi
tissue factor pathway inhibitor
treatment
ISO
RGD
PMID:11776329
RGD:11062085
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
G
Thpo
thrombopoietin
ISO
protein:increased expression:serum:
RGD
PMID:20467749
RGD:10449021
NCBI chr16:20,543,204...20,553,261
Ensembl chr16:20,543,204...20,553,261
G
Tnf
tumor necrosis factor
treatment
ISO
protein:increased expression:peritoneal macrophage, cell surface (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20054000 PMID:2213560 PMID:12622907
RGD:10449465 , RGD:1598936
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Trem1
triggering receptor expressed on myeloid cells 1
ISO
mRNA:decreased expression:polymorphonuclear leukocyte
RGD
PMID:24465168
RGD:126848796
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
Zc3h12a
zinc finger CCCH type containing 12A
IMP
RGD
PMID:23422584
RGD:39938961
NCBI chr 4:125,012,207...125,021,674
Ensembl chr 4:125,012,216...125,021,633
G
Bst2
bone marrow stromal cell antigen 2
ISO
associated with Retroviridae Infections;
RGD
PMID:28381565
RGD:14398820
NCBI chr 8:71,986,899...71,990,116
Ensembl chr 8:71,986,899...71,990,100
G
Il2rb
interleukin 2 receptor, beta chain
ISO
RGD
PMID:29307521
RGD:42724467
NCBI chr15:78,363,456...78,396,569
Ensembl chr15:78,363,456...78,379,471
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all